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Abstract 
With the advent of microarray technology, new approaches have led to promising 
discoveries in life sciences. Microarrays have become a useful tool in biomedical 
research as they can be used to determine simultaneously the relative expression of 
thousands of genes in a given sample.  
However, the impressive quantity of data microarrays provide is associated with a 
substantial amount of noise. Microarray gene expression data are commonly 
perceived as being extremely noisy because of many imperfections inherent in the 
current technology. If the noise is consistent and reproducible it can be filtered from 
the data and some false positives can be eliminated.  
There are two principal sources of noise in microarray experiments: biological noise 
and technical noise.  
Biological noise consists of variation among conditions. Technical noise consists of 
differences in sample preparation and experiment variables which include 
nonspecific cross hybridization, differences in the efficiency of labeling reactions and 
production differences between microarrays. Biological noise cannot be corrected 
but it can be accounted for with statistics using replicates of the treatments or 
conditions. 
However, it is widely believed that a high level of technical noise in microarray data is 
the most critical deterrent to the successful use of this technology in studies of 
normal and abnormal biological processes. In particular, the notorious lack of 
reproducibility of lists of detected genes across platforms and laboratories, as well as 
validation problems associated with prognostic signatures, is frequently attributed to 
this "flaw" of microarray technology.  
Although several recently proposed analysis methods for microarray data can cope 
with heavy tailed noise, many of them rely on statistical assumptions. These methods 
however can only reduce noise.  
This thesis contributes with two papers that pursue the novel approach of reducing 
microarray data noise. We present a novel concept to organize microarray data to 
ease finding of new pathways and validation of existing ones by using refined 
microarray meta-data and a novel co-expression networks visualization tools with 
advanced features to manipulate generated (sub) networks.  
These approaches consist of applying complex computational processes to enrich 
microarray meta-data annotations by use of different biological information. 
The resulting applications have been carefully evaluated and confirm their biological 
phenomenon’s predictive and validation powers.  
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Introduction 
 
Background 
Microarrays, a new technology that makes it possible to examine the expression of 
thousands of genes simultaneously, opened up an entire new world to researchers 
(CAMPBELL, et al., 2011) .They are now not restricted to studying a unique single 
aspect of a life mechanism; instead one can explore a genome-wide view of complex 
interactions (Wu, et al.). This new technology is helping scientists discover and 
understand disease pathways, and ultimately develop better methods of detection, 
treatment, and prevention of different diseases (Drews, 2000). Data generated from 
whole-genome microarray studies are richer and deeper than ever before.  
Data from a single array experiment – whether gene expression or DNA analysis – can 
often be used for a number of different studies that otherwise would have required 
the compilation of data from numerous independent experiments. For example, the 
same expression data from a study could be used to understand the mechanism of 
another study. Moreover, arrays are being designed to simultaneously monitor 
whole-genome, providing a complete view of how different biological mechanisms 
operate. Also, the flexibility of microarray analysis allows a single array and a single 
experiment to encompass different types of studies. 
 
Overview of microarrays 
The final deciphering of the complete human genome, together with the 
improvement of high throughput technologies such as Microarrays (Pease, et al., 
1994) (Schena, et al., 1995), is causing a fundamental transformation in life sciences 
research. This technique makes it possible to examine the expression of thousands of 
genes simultaneously (Shalon, et al., 1996). 
By using a microarray containing many DNA samples, researchers can determine, in a 
single experiment, the expression levels of hundreds or thousands of genes within a 
cell by measuring the amount of mRNA bound to each site on the array (Shalon, et 
al., 1996). With the aid of a computer, the amount of mRNA bound to the spots on 
the microarray is precisely measured, generating a profile of gene expression in the 
cell.  
 
 
 
2 
 
 
Gene expression 
Gene expression is the process by which information from a gene is used in the 
synthesis of a functional gene product (Figure 1). These products are often proteins, 
but in non-protein coding genes such as ribosomal RNA (rRNA) genes or transfer RNA 
(tRNA) genes, the product is a functional RNA. The process of gene expression is used 
by all known life - eukaryotes (including multicellular organisms), prokaryotes 
(bacteria and archaea) and viruses - to generate the macromolecular machinery for 
life. Several steps in the gene expression process may be modulated, including the 
transcription, RNA splicing, translation, and post-translational modification of a 
protein.  
 
 
Figure 1 - Molecular biology paradigm (Source: http://upload.wikimedia.org/Genetic_code.png) 
 
What is a Microarray? 
A Microarray is a new powerful tool for studying the molecular basis of interactions 
on a scale that is impossible using conventional analysis (Wilson, et al., 2006). It 
consists of an arrayed series of thousands of microscopic spots of DNA 
oligonucleotides, called features. Each of these features contains picomoles (10−12 
moles) of a specific DNA sequence, known as probes (or reporters) (Huynh, et al., 
2009) (Ganguly, et al., 2010). These probes can be a short section of a gene or other 
DNA elements that are used to hybridize a cDNA (Pollack, et al., 1999) or cRNA 
sample (called target) under high-stringency conditions (Figure 2). Probe-target 
hybridization is usually detected and quantified by detection of fluorophore-, silver-, 
or chemiluminescence-labeled targets to determine relative abundance of nucleic 
acid sequences in the target (Shalon, et al., 1996). Since an array can contain tens of 
thousands of probes, a microarray experiment can accomplish many genetic tests in 
parallel. Therefore arrays have dramatically accelerated many types of investigation 
(Bell, et al., 2010). 
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Figure 2 - Hybridization principle (Source: http://upload.wikimedia.org/NA_hybrid.png) 
In standard microarrays, the probes are attached via surface engineering to a solid 
surface by a covalent bond to a chemical matrix (via epoxy-silane, amino-silane, 
lysine, polyacrylamide or others) (Figure 2). The solid surface can be glass or a silicon 
chip, in which case they are colloquially known as an Affychip1 or GeneChip when an 
Affymetrix chip is used. Other microarray platforms, such as Illumina2, use 
microscopic beads, instead of the large solid support. DNA arrays are different from 
other types of microarray only in that they either measure DNA (Pollack, et al., 1999) 
or use DNA as part of its detection system (Shalon, et al., 1996). 
The core principle behind microarrays is hybridization between two DNA strands, the 
property of complementary nucleic acid sequences to specifically pair with each 
other by forming hydrogen bonds between complementary nucleotide base pairs. A 
high number of complementary base pairs in a nucleotide sequence mean tighter 
non-covalent bonding between the two strands. After washing off of non-specific 
bonding sequences, only strongly paired strands will remain hybridized. So 
fluorescently labeled target sequences that bind to a probe sequence, generate a 
signal that depends on the strength of the hybridization. The strength of 
hybridization, however, is determined by the number of paired bases, the 
hybridization conditions and washing after hybridization. Total strength of the signal, 
from a spot depends upon the amount of target sample binding to the probes 
present on that spot (Fang).  
In addition, microarrays use relative quantization in which the intensity of a feature is 
compared to the intensity of the same feature under a different condition (Sassolas, 
                                                   
1
 www.affymetrix.com 
2
 www.illumina.com 
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et al., 2007), and the identity of the feature is known by its position on the array 
(Figure 3). 
Many types of arrays exist and the broadest distinction is whether they are spatially 
arranged on a surface or on coded beads:  
 The traditional solid-phase array is a collection of orderly microscopic "spots", 
called features, each with a specific probe attached to a solid surface, such as 
glass, plastic or silicon biochip (commonly known as a genome chip, DNA chip 
or gene array). Thousands of them can be placed in known locations on a 
single DNA microarray.  
 The alternative bead array is a collection of microscopic polystyrene beads, 
each with a specific probe and a ratio of two or more dyes, which do not 
interfere with the fluorescent dyes used on the target sequence. 
 
 
 
 
 
 
 
 
Categories of DNA microarrays 
Microarrays can be categorized in different ways, depending on the number of 
probes under examination, costs, customization requirements, number of channels 
(dyes) and the type of scientific question being asked. Arrays may have as few as 10 
probes or up to 2.1 million micrometer-scale probes from commercial vendors 
(Kumar, 2011). 
 
 
 
Figure 3 - Example of an Affymetrix Genechip manufacture process and working principle (Sources: 
http://www.affymetrix.com/GeneChip.gif) 
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Categorization by fabrication technologies 
Microarrays can be fabricated using a variety of technologies, including printing with 
fine-pointed pins onto glass slides, photolithography using pre-made masks, 
photolithography using dynamic micro mirror devices, ink-jet printing, or 
electrochemistry on microelectrode arrays (Kumar, 2011) (XiaoKun and HuaSheng, 
2009).  
 
Spotted microarrays 
In spotted microarrays, the probes are cDNA or small fragments of PCR3 products 
that correspond to mRNAs (Hubank and Schatz, 1994). The probes are synthesized 
prior to deposition on the array surface and are then "spotted" onto glass. A common 
approach utilizes an array of fine pins or needles controlled by a robotic arm that is 
dipped into wells containing DNA probes and then depositing each probe at 
designated locations on the array surface (Schena, et al., 1995) (Eisen and Brown, 
1999). The resulting "grid" of probes represents the nucleic acid profiles of the 
prepared probes and is ready to receive complementary cDNA or cRNA "targets" 
derived from experimental or clinical samples.  
This technique is used by research scientists around the world to produce "in-house" 
printed microarrays from their own labs. These arrays may be easily customized for 
each experiment, because researchers can choose the probes and printing locations 
on the arrays, synthesize the probes in their own lab (or collaborating facility), and 
spot the arrays. They can then generate their own labeled samples for hybridization, 
hybridize the samples to the array, and finally scan the arrays with their own 
equipment. This approach provides a relatively low-cost microarray that may be 
customized for each study, and avoids the costs of purchasing often more expensive 
commercial arrays that may represent vast numbers of genes that are not of interest 
to the investigator.  
 
 
 
 
 
                                                   
3
 PCR refers to Polymerase Chain Reaction 
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oligonucleotide microarrays 
In oligonucleotide microarrays, the probes are short sequences designed to match 
parts of the sequence of known or predicted open reading frames. Although 
oligonucleotide probes are often used in "spotted" microarrays, the term 
"oligonucleotide array" most often refers to a specific technique of manufacturing.  
Oligonucleotide arrays are produced by printing short oligonucleotide sequences 
designed to represent a single gene or family of gene splice-variants (Maskos and 
Southern, 1992) (Fodor, et al., 1993). This is achieved by synthesizing this sequence 
directly onto the array surface instead of depositing intact sequences (Schena, et al., 
1995). Sequences may be longer (60-mer probes such as the Agilent design) or 
shorter (25-mer probes 4produced by Affymetrix) depending on the desired purpose. 
Longer probes are more specific to individual target genes while shorter probes may 
be spotted in higher density across the array and are cheaper to manufacture (Eisen 
and Brown, 1999).  
One technique used to produce oligonucleotide arrays include photolithographic 
synthesis (Agilent5 and Affymetrix (Figure 4)) on a silica substrate where light and 
light-sensitive masking agents are used to "build" a sequence one nucleotide at a 
time across the entire array (Pease, et al., 1994). Each applicable probe is selectively 
"unmasked" prior to bathing the array in a solution of a single nucleotide, then a 
masking reaction takes place and the next set of probes are unmasked in preparation 
for a different nucleotide exposure. After many repetitions, the sequences of every 
probe become fully constructed. More recently, Maskless Array6 Synthesis from 
NimbleGen Systems has combined flexibility with large numbers of probes (Nuwaysir, 
et al., 2002). 
 
 
 
                                                   
4
 This is a conventional length for oligonucleotide probe.  
5
 www.agilent.com 
6
 www.nimblegen.com 
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Categorization based on number of dyes 
Considering channels (dyes) number criteria, microarrays can be subdivided into two 
categories: 
Two-dye microarrays 
Two-color microarrays or two-channel microarrays are typically hybridized with cDNA 
prepared from two samples to be compared (e.g. diseased tissue versus healthy 
tissue) and that are labeled with two different fluorophores (Schena, et al., 1995). 
Fluorescent dyes commonly used for cDNA labeling include Cy3, which has a 
fluorescence emission wavelength of 570 nm (corresponding to the green part of the 
light spectrum), and Cy5 with a fluorescence emission wavelength of 670 nm 
(corresponding to the red part of the light spectrum) (Welford, et al., 1998). The two 
Cy-labeled cDNA samples are mixed and hybridized to a single microarray that is then 
scanned in a microarray scanner to visualize fluorescence of the two fluorophores 
after excitation with a laser beam of a defined wavelength (Widengren and Schwille, 
2000) (Huang, et al., 2005). Relative intensities of each fluorophore may then be used 
to identify up-regulated and down-regulated genes (Tang, et al., 2007). 
 
 
 
Figure 4 - Examples of oligonucleotide microarrays: AFFYMETRIX & AGILENT  
(A; source: http://www.affymetrix.com) – Agilent (B; source: http://www.agilent.com) 
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One-dye microarrays 
In single-channel microarrays or one-color microarrays, the arrays provide intensity 
data for each probe or probe set indicating a relative level of hybridization with the 
labeled target (Torimura, et al., 2001) (Heinlein, et al., 2003). However, they do not 
truly indicate abundance levels of a gene but rather relative abundance when 
compared to other samples or conditions when processed in the same experiment. 
Each RNA molecule encounters protocol and batch-specific bias during amplification, 
labeling, and hybridization phases of the experiment making comparisons between 
genes for the same microarray uninformative (Widengren and Schwille, 2000) 
(Huang, et al., 2005).  
The comparison of two conditions for the same gene requires two separate single-
dye hybridizations. Several popular single-channel systems are the Affymetrix "Gene 
Chip", Illumina "Bead Chip", and Agilent single-channel arrays. One strength of the 
single-dye system lies in the fact that an aberrant sample cannot affect the raw data 
derived from other samples, because each array chip is exposed to only one sample 
(Harvey and Levitus, 2009) (as opposed to a two-color system in which a single low-
quality sample may drastically impinge on overall data precision even if the other 
sample was of high quality). Another benefit is that data are more easily compared to 
arrays from different experiments so long as batch effects have been accounted for 
(Chen, et al., 2009). A drawback to the one-color system is that, when compared to 
the two-color system, twice as many microarrays are needed to compare samples 
within an experiment. 
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DNA Microarrays and Bioinformatics 
 
Experimental design 
Due to the biological complexity of gene expression, the considerations of 
experimental design are of critical importance if statistically and biologically valid 
conclusions are to be drawn from DNA microarray data.  
There are three main elements to consider when designing a microarray experiment.  
First, replication of the biological samples is essential for drawing conclusions from 
the experiment.  
Second, technical replicates (two RNA samples obtained from each experimental 
unit) help to ensure precision (Cui, et al., 2005) and allow for testing differences 
within treatment groups.  
The biological replicates include independent RNA extractions while technical 
replicates may be two aliquots of the same extraction.  
Third, spots of each cDNA clone or oligonucleotide are present as replicates (at least 
duplicates) on the microarray slide, to provide a measure of technical precision for 
each hybridization. 
Nevertheless, while it is preferable to have as many replicates as possible (Lin, et al., 
2002), the high cost of chips makes it more practical; hence the use of smaller 
number of replicates is preferred. To determine the number of replicates, biologists 
must balance confidence, cost and efficiency against the desire to explore more 
experimental conditions.  
Regardless of the replication strategy, sample-to-sample variability cannot, in 
general, be completely minimized (Nagele, 2003). Thus, it is important to consider the 
best ways to maximize consistency between samples. In many types of studies, it is 
not possible to control completely all variables, and there may be considerable 
variability due to experimental difficulties or individual genetic variation. But such 
factors do not preclude the discovery of some genes that are consistently different 
and that clearly ‘cluster’ or differentiate between the sample sets. 
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Standardization 
Microarray data is difficult to exchange due to the lack of standardization in platform 
fabrication, assay protocols, and analysis methods (Mwololo, et al., 2010). This 
presents an interoperability problem in bioinformatics. Various grass-roots open-
source projects are trying to ease the exchange and analysis of data produced with 
non-proprietary chips: 
For example, the "Minimum Information About a Microarray Experiment" (MIAME) 
(Brazma, et al., 2001) checklist helps define the level of detail that should exist. 
However MIAME does not describe the format for the information (no verification of 
complete semantic compliance). 
 
Statistical Data analysis 
Analytical precision is influenced by a number of variables. Challenges include taking 
into account effects of background noise and appropriate normalization of the data 
(Bolstad, 2002). Different normalization methods (Figure 5) may be suited to specific 
platforms and, in the case of commercial platforms, the analysis may be proprietary.  
Some algorithms that affect statistical analysis include: 
 Image analysis: gridding, spot recognition of the scanned image (segmentation 
algorithm), removal or marking of poor-quality and low-intensity features 
(called flagging) (Korn, et al., 2004). 
 Data processing: background subtraction (based on global or local 
background), determination of spot intensities and intensity ratios, 
visualization of data (e.g. see MA plot), and log-transformation of ratios, global 
or local normalization of intensity ratios (Wang, et al., 2001). 
 Identification of statistically significant changes: t-test, ANOVA, Bayesian 
method (Ben-Gal, et al., 2005) Mann–Whitney test methods tailored to 
microarray data sets, which take into account multiple comparisons (Leung 
and Cavalieri, 2003) or cluster analysis (Priness, et al., 2007). These methods 
assess statistical power based on the variation present in the data and the 
number of experimental replicates, and can help minimize Type I and type II 
errors in the analyses. 
 Network-based methods: Statistical methods that take the underlying 
structure of gene networks into account, representing either associative or 
causative interactions or dependencies among gene products (Wei, et al., 
2004). 
11 
 
Sometimes, microarray data may require further processing aimed at reducing the 
dimensionality of the data to aid comprehension and more focused analysis 
(Wouters, et al., 2003). Other methods permit analysis of data consisting of a low 
number of biological or technical replicates.  
For example, the Local Pooled Error (LPE) test pools standard deviations of genes 
with similar expression levels in an effort to compensate for insufficient replication 
(Jain, et al., 2003). 
For the purpose of this research, in this thesis, we limit our analytical discussion on 
Affymetrix-made microarrays while there are an optimal number of biological or 
technical replicates. 
 
 
 
 
 
The major issue when studying datasets with few replicates is the decreased power 
of the analysis (Shriner and Vaughan). To compensate for this lack of information 
about expression data generated by microarrays, some researchers have tried to 
work at the probe level, breaking down probesets into small components called 
probes. In Affymetrix technology, each gene is typically represented by a set of 11-20 
pairs of probes. In order to obtain expression measures, probe level data are 
summarized by application of a series of improved preprocessing methods (Yin, et 
al.). 
 
Figure 5 - Example of steps involved in most of microarray data analysis 
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Probe-level Analysis 
There are dozens (thousands if you consider mixing and matching) of approaches to 
preprocessing (Nadon and Shoemaker, 2002) but they are generally classified into the 
following steps:  
 Background adjustment (this step combine background correction PM 
correction in many methods) 
 Normalization 
 Summarization 
Professor Eric Depiereux bioinformatics team have put extraordinary efforts on 
developing new probe-level statistical methods 7ranging from data filters to novel 
analysis approaches. Several such methods have been developed so far (Goeman and 
Buhlmann, 2007), but, this research focuses on some popular (Table 1) methods 
which comprise basic tools for much experimental work. 
Due to the fact that the Professor Depiereux bioinformatics team focuses only on 
Affymetrix platform, our discussion in this thesis is limited to Affymetrix DNA 
microarrays, other existing platforms falling beyond the scope of this thesis work.
                                                   
7
 My DEA thesis "Analyse statistique des micropuces à ADN: Développement d'un filtre sur les probes par le 
biais de matrices de fréquences visant à élimininer les probes non-performants" focused mainly on filtering 
noise at probe-level. I developped a frequency table correlation based filter to remove non-performing 
probes). 
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Table 1 - Summary of major Affymetrix microarray data preprocessing methods 
Methods Background correction Normalization Perfect Match 
correction 
Summarization 
RMA                                   
(Robust Multichip Averaging)  
Rma  (Bolstad, et al., 2003) quantiles pmonly medianpolish 
MAS                                  
(Microarray Affymetrix Suite) 
Mas (Affymetrix, 2001)  mas mas mas 
GCRMA  Gcrma  (Wu, et al., 2004) quantiles pmonly medianpolish 
Custom Methods rma                    
 rma2                    
 mas                  
gcrma-eb        
gcrma-mle 
quantiles 
quantiles.robust 
loess 
contrast 
constant 
invariantset 
qspline 
vsn 
 
 
 
pmonly 
mas 
subtractmm 
 
medianpolish 
avdiff 
liwong 
mas 
playerout 
rlm 
Comparison of popular Affymetrix GeneChip pre-processing methods and the way some of them are combined as a single 
methodology into major R packages. These packages are (some of them) proprietary packages and license issues apply.  
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Major Affymetrix-related preprocessing steps 
 
Background adjustment 
The first step is generally to background adjustment the intensity reading for each 
spot. Background fluorescence can arise from many sources, such as non-specific 
binding of labeled sample to the array surface, processing effects such as deposits left 
after the wash stage or optical noise from the scanner (Wu, et al., 2004).  There is 
always some level of background noise, even when nothing but sterile water is 
labeled and hybridized to the array, some fluorescence will still be picked up by the 
scanner. Different algorithms will use different methods of background correction. 
Only three background adjustment methods will be described here. 
 
RMA convolution  
This is an implementation of the background adjustment carried out as part of the 
RMA method (Irizarry, et al., 2003). These authors found various problems with using 
the Mismatch (MM) probes in the preprocessing steps and proposed a procedure 
that uses only the Perfect Match (PM) intensities. In this procedure, the PM values 
are corrected, array by array, using a global model for the distribution of probe 
intensities. The model was motivated by the empirical distribution of probe 
intensities. In particular the observed PM probes are modeled as the sum of a 
Gaussian noise component, N, with mean μ and variance σ2 and an exponential signal 
component, S, with mean α. To avoid the possibility of negatives expression values, 
the normal distribution is truncated at zero. Given that we have the observed 
intensity, X, then this leads to the following adjustment. 
 
.))(),...,((
int),...,(
)/()(
)/()(
))
1)()(
)()(
(
1)()(
)()(
1()/(
1)()(
)()(
)/(
--S a
S)b,0,N(a, ~/
)Exp( ~),( ~N~
,
1
1
22
2
2
valuescorrectedbackgroundbeingSgSg
andensitiesobersvedofsampleabeingSS
SXVSh
SXESg
b
a
b
aS
b
aS
b
a
b
a
b
aS
b
aS
b
aS
b
a
b
a
bSXV
b
a
b
aS
b
aS
b
a
baSXE
b
SX
XandNwhere
NXS
n
n
 
Equation 1 - RMA convolution method computation 
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MAS 5.0 background correction  
In this background adjustment method (Affymetrix, 2002), the chip is divided into a 
grid of k (default k = 16) rectangular regions. For each region, the lowest 2% of probe 
intensities are used to compute a background value for that grid. Then probe 
intensity is adjusted based upon a weighted average of each of the background 
values. The weights are dependent on the distance between the probe and the 
centroid of the grid. In particular, the weights are: 
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Equation 2 - MAS 5.0 background adjustment computation 
 
Special care is taken to avoid negative values or other numerical problems for low 
intensity regions. Note this method corrects both PM and MM probes. 
 
Ideal mismatch  
Originally, the suggested purpose of the MM probes was that they could be used to 
adjust the PM probes (Affymetrix, 2001) for probe-specific non-specific binding by 
subtracting the intensity of the MM probe from the intensity of the corresponding 
PM probes. However, this becomes problematic because, for data from a typical 
array, as many as 30% of MM probes have intensities higher than their corresponding 
PM probe (Naef and Magnasco, 2003).  
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Thus, when raw MM intensities are subtracted from the PM intensities many 
negative expression values result, which makes little sense, because an expression 
value should not be below zero.  
Another drawback is that the negative values preclude the use of logarithms. To 
remedy the negative impact of using raw MM values, Affymetrix introduced the 
concept of an Ideal Mismatch (IM) which was guaranteed, by design, to be smaller 
than the corresponding PM intensity. The goal is to use MM when it is physically 
possible and a quantity smaller than the PM in other cases. This is done by computing 
the specific background, (SB), for each probeset. This is a robust average of the log 
ratios of PM to MM for each probe pair in the probeset. If i is the probe and k is the 
probeset, then for the probe pair indexed by i and k the ideal mismatch IM is given 
by: 
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Equation 3 - IM background method computation 
 
The adjusted PM intensity is obtained by subtracting the corresponding IM from the 
observed PM intensity. 
 
Normalization 
The purpose of this step is to adjust data for technical variation, as opposed to 
biological differences between the samples. There will always be slight discrepancies 
between the hybridization processes for each array and these variations tend to lead 
to scaling differences between the overall fluorescence intensity levels of various 
arrays. For example the quantity of RNA in a sample, the amount of time for which a 
sample spends hybridizing or the volume of a sample can all introduce significant 
variance. Even subtle physical differences between arrays or between the scanners 
used to read arrays can have an effect. Put simply, normalization ensures that when 
17 
 
comparing expression levels of different arrays that we are, as much as is possible, 
comparing like with like (Watson, et al., 2007).  
 
With reference chip 
Scaling: For this normalization method, a baseline array is chosen and all the other 
arrays are scaled to have the same mean intensity as this array. This is equivalent to 
selecting a baseline array and then fitting a linear regression, without an intercept 
term, between each array and the chosen array. Then, the fitted regression line is 
used as the normalizing relationship. One modification is to remove the highest and 
lowest intensities when computing the mean, that is, a trimmed mean is used. 
Affymetrix removes the highest and lowest 2% of the data. Affymetrix has proposed 
using scaling normalization (Robinson and Oshlack) after the computation of 
expression values, but it may also be used on probe-level data. Another modification 
is to use a target mean value in place of the mean intensity on the baseline array. 
Non-linear methods: Methods that perform non-linear adjustments between arrays 
have been proposed and tend to out-perform linear adjustments such as the scaling 
method. Numerous non-linear relationships have been proposed including cross-
validated splines (Schadt, et al., 2001), running median lines (Li and Hung Wong, 
2001), and loess smoothers (Bolstad, et al., 2003). For a typical implementation, the 
normalizing relationship is fitted using a rank-invariant set of points, that is, a set of 
points that has same rank ordering on each array.  
 
Without reference chip 
Quantile normalization: The goal of quantile normalization is to impose the same 
empirical distribution of intensities to each array. A quantile-quantile plot will have a 
straight diagonal line, with slope 1 and intercept 0, if two data vectors have the same 
distribution. This kind of quantile normalization method is not the only normalization 
method based upon quantiles (Workman, et al., 2002) (Amaratunga, et al., 2001).  
Cyclic loess: The cyclic loess method is a generalization of the global loess method 
(Yang, et al., 2002), where Cy5 and Cy3 channel intensities are normalized on cDNA 
microarrays by using MA-plots. When dealing with single-channel array data, it is 
pairs of arrays that are normalized to each other. The cyclic loess method normalizes 
intensities for a set of arrays by working in a pairwise manner. With only two arrays, 
the algorithm is identical to that in Yang et al. (2002b). With more than two arrays, 
only part of the adjustment is made. In this case, the procedure cycles through all 
pairwise combinations of arrays, repeating the entire process until convergence. One 
drawback is that this procedure requires O (n2) loess normalizations although usually 
only one or two complete cycles through the data are required. 
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Contrast normalization: The contrast normalization method (Bolstad, et al., 2003) is 
another generalization of the methods described by Yang et al. (2002b). In brief, the 
data are transformed to a set of contrasts, a non-linear MA-plot normalization is 
performed, and then a reverse transformation is applied. It requires only O (n) loess 
normalizations, which is considerably fewer than with the cyclic loess method. As 
with the cyclic loess method, a subset of the data can be used to fit the loess curves, 
leading to considerably reduced running times. One way that the subset may be 
chosen is to use a rank-invariant set of probes. 
 
Summarization 
It is the process of combining the multiple probe intensities for each probeset to 
produce an expression value. There are a number of different ways that this can be 
achieved, but the end result is always a single expression value for each gene on each 
chip. 
 
Analysis packages  
Most of the times, the preprocessing methods described above are combined in 
single analysis packages such as RMA, GCRMA (GC Robust Multichip Averaging) and 
others. They provide quite general facilities for computing expression summary 
values. In particular they allow most background adjustment, normalization, and 
summarization methods to be combined. The choice of preprocessing method can 
have enormous influence on the quality of the ultimate results (van de Wiel, et al., 
2010). It is important to assess different methods before proceeding to more 
downstream analysis. 
 
Probeset-level analysis 
Although some researchers have focused their statistical analyses on probes, many of 
them still prefer to work at the probeset-level, where data can be analyzed in 
different layers (individual analysis, geneset8 analysis, co-expression analysis and 
clustering) (Berger, et al.). 
 
 
                                                   
8
 Geneset refers to a group of genes. 
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Detecting differentially expressed genes 
 
Single Gene Approach 
After removing the bad quality data we are left with reliable data. As we have already 
seen, good quality data can be further filtered so that only the genes that show some 
changes in the expression during the experiment are preserved in the dataset 
(Cooper and Shedden, 2003). Often the differentially expressed or otherwise 
interesting genes are stored as simple lists of gene names, i.e., genelists9.  
There exist many statistical test methods based on number of sample groups and 
replicates (Table 2). In this thesis, we will briefly and only cover some of the popular 
existing algorithms and present novel approaches we developed during the course of 
this thesis work. Among these, are statistical variants of t-tests and fold change. 
Sometimes it is sufficient to get information about genes that are either under- or 
over-expressed during the experiment (Santarius, et al.). For example, we might be 
interested in genes that have an elevated expression because of a drug treatment. 
Such genes are most easily found by simple filtering. Simple filtering can even be used 
for experiments, where there are no replicates (Lu, et al.). 
Also, in single gene differential expression analysis, if the log-transformed data is 
used, the over-expressed genes have an expression above zero and under-expressed 
genes have an expression below zero. However, often the experimental errors are of 
the order of two, and for finding the over- and under-expressed genes the cutoffs of -
1 and 1 are used. All the genes which fulfill the filter criteria are saved in a new gene 
list.  The filtering by absolute expression change is not always the optimal method for 
finding the differentially expressed genes, because the information about the 
reliability of the expression change is lacking (Lai). In the absence of replicates, there 
are still a few statistical methods that can be used, if we want to have statistical 
significance values for expression changes. However, using such methods carries the 
risk that the most unstable probes or mRNAs are identified as differentially expressed 
(Stylianou, et al., 2008).  
However, there exist clear advantages of statistical t-test over fold change threshold 
for selecting differentially expressed genes (McCarthy and Smyth, 2009) (Murie, et 
al., 2009).   
These advantages include among others: 
                                                   
9
 Genelist refers to an assumed list of genes belonging to the same group for a specific purpose. 
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 Incorporation of variation between measurements, 
 Estimation for error rate, 
 Detection of minor changes, 
 Ranking of differentially expressed genes. 
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Table 2 - Summary of algorithms which may help users to select statistical testing methods based on the number of sample groups and replicates and potential correction methods. 
Sample 
Groups 
Sample 
Replicates 
Basic Statistical Method Multiple Testing Procedure Gene (feature) Limit 
Options 
Main result files 
1 Any None None None None 
2 
< 3 in either 
group 
Average values of each gene (feature) within group 
Calculate fold change of each gene between groups 
None 
Fold Change 
Total number of 
genes 
User gene list 
Gene list 
Fold changes 
Expression values 
Heatmap of top 
genes 
≥3 in both 
groups 
two-sample Welch t-test (unequal variances) 
two-sample t-test (equal variances) 
standardized rank sum Wilcoxon test 
paired t-test 
Options for Raw/Nominal p-value calculation: 
Parametric 
Permutation 
Options for Side/Rejection Region: abs, upper, lower 
Bonferroni single-step FWER 
Holm step-down FWER 
Hochberg step-up FWER 
Sidak single-step FWER 
Sidak step-down FWER 
Benjamini & Yekutieli step-up FDR 
Benjamini & Hochberg step-up 
FDR 
Storey q-value single-step pFDR 
Westfall & Young maxT 
Fold Change 
 Limit to 
Total number of genes 
adjusted p-values 
raw p-values 
test statistics 
User gene list 
Gene list 
Fold changes 
Statistic 
Raw p-values 
Adjusted p-values 
Expression values 
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permutation FWER 
 Westfall & Young  
minP permutation FWER 
3 
≤3 in any group 
Calculate percentile of standard deviation (SD) of each 
gene cross all samples 
Select genes by a SD percentile cutoff 
 
Standard Deviation 
(SD) 
Total number of 
genes 
User gene list 
Gene names 
Standard 
Deviation 
Expression values 
≥3 in all groups 
F-test 
Block F-test 
Options for Raw/Nominal p-value calculation: 
Parametric 
Permutation 
Options for Side/Rejection Region: abs, upper, lower 
Bonferroni single-step FWER 
Holm step-down FWER 
Hochberg step-up FWER 
Sidak single-step FWER 
Sidak step-down FWER 
Benjamini & Yekutieli step-up FDR 
Benjamini & Hochberg step-up 
FDR – selected 
Storey q-value single-step pFDR 
Westfall & Young maxT 
permutation FWER 
Westfall & Young minP 
permutation FWER 
Total number of 
genes 
User gene list 
Gene names 
Statistic value 
Expression values 
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Single Gene Differential Expression Analysis 
To assess the confidence of an experiment analysis, we need to determine the 
statistical significance of the Up/Down-regulation of the gene. Significance can only 
be assessed, if replicate measures of the same gene were performed during the 
experiment (Siddiqui, et al., 2006). If the gene expression has been measured for 
control and treatment, but only treatment has been replicated, the experimental 
error can be crudely estimated from the variation between the replicates (Schneider 
and Roossinck, 2001). The standard deviation is determined for every gene, and the 
expression change is compared with the standard deviation. The more the change 
exceeds the standard deviation between replicates, the more significant the gene is 
(Bozinovic, et al.). However, this method does not allow for the calculation of p-
values.  
 
Parametric tests 
When conducting this kind of classical t-tests, researchers assume that data fits a 
normal distribution (Goddard and Hinberg, 1990) (however this assumption vanishes 
when dealing with a larger number of conditions [n>30] and Kolmogorov-Smirnov 
(Young, 1977) or Shapiro-Wilk (Henderson, 2006) tests remain formal tests for 
normality Q-Q plots), tests are independent and gene expression levels have equal 
variance across conditions. Additionally, the following conditions should clearly be 
considered when applying classical t-tests (Hoaglin, et al., 2000): 
 One condition with multiple replicates (one-sample t-test): Up- and down-
regulated genes can be more effectively found, if the chips are replicated. In 
such cases, the one-sample t-test for the deviation from zero (expected mean) 
can be performed. This indicates that new chip technology coupled with an 
appropriate number of replicates can produce reliable data even for very small 
expression changes. 
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Equation 4 - Classic t-test computation 
 Two conditions with multiple replicates (two-sample t-test): The two-sample 
t-test looks at the mean and variance of the two distributions (say, control and 
treatment chip log ratios), and calculates the probability that they were 
sampled from the same distribution. The t-test can be applied successfully in 
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situations, where both the control and treatment have been repeated. After 
calculating the t-test p-values for the replicated genes, the ones with the 
lowest p-value are the ones which most significantly differ between two 
conditions, say control and treatment. 
 Multiple conditions with multiple replicates (ANOVA): In this case, the 
fundamental idea behind analysis of variance (ANOVA) is that, given an 
appropriate experimental design, variability in the quantity being measured 
(gene expression) can be partitioned into various identifiable sources. The 
assumed sources of variability will include the experimental factors, as well as 
random noise.  There are a number of assumptions which must be made 
before ANOVA can be applied; deviation from the assumptions will lead to 
misleading or inaccurate results. These assumptions include the 
independence, normality, and uniformity of variance of the errors. 
Importantly, we assume (or at least hope) that the linear model we select is 
adequate to describe the data. In some situations, there are adjustments that 
can be made to reduce violations of these assumptions, such as log 
transformation of the data, and there are well-established methods for 
diagnosing the quality of the results. However, for microarray data, there are 
likely to be genes for which the assumptions are valid and others for which 
they are not. The situation may improve for some genes and worsen for others 
after correction attempts. The use of non-parametric methods can greatly 
reduce the reliance on prior assumptions about the data, but also incur a loss 
of power.   
 
Non-parametric tests 
Instead of parametric t-test, which assumes that the expression values are normally 
distributed non-parametric tests like Mann-Whitney U test (two groups) or Kruskal-
Wallis test (two or more groups) can be applied, especially if the expression values 
are not normally distributed.  
Gene expression values don’t follow a normal curve, but the p-values from a standard 
t-test aren’t far away from truth when the distribution is moderately asymmetric 
(Hollander, et al., 1999). However the t-test does fall down badly when there are 
outliers (values more than twice as far from the mean as all the others). For this 
reason, when doing a t-test, it is wise to confirm that neither group contains outliers. 
In practice, it often happens that genes detected as different between groups, are 
actually expressed very highly in only one individual of the higher group. Probably the 
best way to avoid the problem with outliers is to use robust estimates of mean 
(trimmed mean) and variability (mean absolute deviation). However no theoretical 
25 
 
distribution is known for these; and their significance levels (p-values) would have to 
be computed by permutations. 
 
Multiple testing problem 
 
P-Values and False Discovery Rates 
If the aim of the microarray study is to select a few genes for more precise study, 
then the goal is an ordered list of genes, most of which are really different (true 
positives). Another way to say this is that the expected number of false positives is 
some reasonable fraction of the genes selected. This goal leads naturally to specifying 
the false discovery rate (FDR) (Yarden and Sliwkowski, 2001) for a list, rather than 
significance level (false positive rate). The FDR is the expected fraction of false 
positives in a list of genes selected applying a particular statistical procedure. If 
applying this procedure in many experiments would give gene lists including twenty 
per cent false positives, on average, then the procedure's FDR is 20%. The FDR is 
distinct from the false positive rate (FPR), which is the rate at which truly unchanged 
genes appear as false positives.  
 
Multiple Testing P-Values and False Positives 
Suppose you compare two groups of samples drawn from the same larger group, 
using a chip with 20,000 genes on it. On average 1000 genes will appear ‘significantly 
different’ at a 5% threshold. For these genes, the variation between samples will be 
large relative to the variation within groups due to random, but uneven allocation of 
the expression values to the treatment and control groups. Therefore the p-value 
appropriate to a single test situation is inappropriate to presenting evidence for a set 
of changed genes (Westfall, et al., 1993). Statisticians have devised several 
procedures for adjusting p-values to correct for the multiple comparisons problem.  
 
Multiple testing correction methods 
There are two ways of controlling multiple testing error rates (Gordon, et al., 2007): 
 Family-wise error rate (FWER): used to correct for the probability of at least 
one type I error (Methods: Bonferroni-Holm, Benjamin-Hochberg …) 
 False Discovery Rate (FDR): used to correct proportion of type I errors among 
rejected hypotheses (Methods: fdr…) 
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One way to improve such statistical analyses is to integrate biological information in 
the design of these analyses. During the course of this thesis, we have used the 
relationship between the level of gene expression and variability. Using this biological 
information, we have proposed to integrate the information from multiple genes to 
get a better estimate of individual gene variance, when a small number of replicates 
are available, to increase the power of the statistical analysis. We described a 
strategy named the “Window t test” (Berger, et al., 2008) that uses multiple genes 
which share a similar expression level to compute the variance which is then 
incorporated a classic t test. The performances of this new method were evaluated 
by comparison with classic and widely-used methods for differential expression 
analysis (the classic Student t test, the Regularized t test (reg t test), SAM, Limma, LPE 
and Shrinkage t). In each case tested, the results obtained were at least equivalent to 
the best performing method and, in most cases, outperformed it. Moreover, the 
Window t test relies on a very simple procedure requiring small computing power 
compared with other methods designed for microarray differential expression 
analysis. 
However, the sensibility of microarray data analysis tools and methods is strongly 
limited by the weakness of the estimation of variance because the number of 
replicates is generally low and variance heterogeneity high. The above mentioned 
methods and their variants have tried to increase this sensitivity by improving the 
estimation of variance. However, these methods are generally evaluated and/or 
tested on artificial “spike-in” or simulated data. 
Consequently, the ability of these methods to better estimate variance is tested only 
on technical or modeled variances, and not on biological variances.  
During the course of this thesis, we co-developed and co-authored a novel approach 
to circumvent this limitation by evaluating existing single gene statistical methods on 
actual biological data. This limitation is mainly because the use of actual data does 
not allow for the definition of the unambiguous “truth” to identify true and false 
positives.  
In this work (De Hertogh, et al., 2009), we showed that the Shrinkage t test (close to 
Limma) was the best of the methods tested, except when two replicates were 
examined, where the Regularized t test and the Window t test performed slightly 
better. 
The benchmark method proposed here differs from other approaches published, as 
actual biological and experimental variability is preserved. The obtained Mean – 
Standard deviation relationships confirm that the variance structure of the data we 
studied is closer to biological data than that of spike-in or simulation studies. One 
other advantage of the method lies in the fact that virtually all parameters can be 
fine-tuned, allowing researchers to assess those methods which are truly suited for 
their particular approaches. 
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We applied the benchmark to a set of published methods. The results show better 
performances for the Shrinkage t test, except when there are only two replicates, 
where the Regularized t test and Window t test perform better (Figure 6). 
 
 
 
 
The figure above show the absolute performances of different tested methods. 
Absolute sensitivity versus number of replicates for classic Student's t test, Shrinkage 
t and Regularized t test. From a to d: Runs 1 to 4 (DEGs increasingly difficult to find).In 
this study, the Shrinkage t performs best overall, except for 2 replicates. 
 
Figure 6 - Shrinkage t performance. 
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Single Gene vs Geneset Differential Analysis Dilemma 
The double edged problem of multiple testing and the week variance estimation (due 
to the limited number of replicates) hamper microarray data analyses. 
Departing from normality and variance heterogeneity between genes and between 
experimental conditions for a given gene can decrease the confidence of statistical 
tests. Moreover, data has shown that a non-trivial mean-variance relationship 
benefits to methods analyzing groups of genes. This relies on the fact that n genes 
sharing similar expression levels also share more similar variances than n genes 
sampled randomly. 
 
Geneset Differential Analysis 
Several geneset analysis methods have been proposed to analyze the expression 
values of several genes related by known biological criteria (metabolic pathway, 
pathology signature, co-regulation by a common factor, etc.) at the same time and 
the cost of these methods allows for the use of more values to help discover the 
underlying mechanisms. 
However, geneset differential expression analysis is a far more complex task than the 
single gene analysis of expression changes. The diversity of the biological criteria 
involved and prior definition of the genesets has an impact on the mathematical 
properties of the expression subsets to be analyzed. Furthermore, the diversity of 
available analysis procedures, each based on specific strategies and null hypotheses 
have to address these properties. Thus, design of the analysis strategy is not that 
simple. Current methods involve over-representation analysis (ORA), and functional 
class scoring (FCS). The FCS methods rely either on 2-step (post-hoc) or global 
strategies (using raw data). 
Few methods have tried to solve this issue. Only the FAERI methodology (Berger, et 
al.) tried to solve it. FAERI being a global methodology tailored from a 2-factor 
ANOVA procedure by a 2-step reduction of the data, and is evaluated with respect to 
the self-contained null hypothesis (using label sampling or random data). 
FAERI thus constitutes an improvement over all tested methods, and turns out to be 
the optimal method for testing question: “Which known genesets are associated with 
different expression profiles under the two conditions compared?” 
A real-world example of analysis is reported for three datasets on cellular response to 
hypoxia. The results obtained from analysis of the E-MEXP-445 dataset illustrate that 
FAERI (evaluated using permutations) is able to detect relevant results when a strict 
cut-off is used, compared to the other methodologies. The genesets detected by 
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FAERI are related to three categories, respectively metabolic perturbations, hypoxia 
signaling/response, and hypoxia-related pathologies. The results of other global 
methods confirm these results, and posthoc methods fail to detect any significant 
genesets. The results provided by FAERI from analysis of the two additional datasets 
reveal its ability to detect the same sets using several related datasets. Focusing on 
the top list obtained with several datasets, we showed that 
FAERI not only detects more sets, but also presents a larger intersection of the 
results. 
We proposed to score this last assessment on the whole list of sets by computing the 
Pearson (Pearson, 2008) correlation coefficient on the ranked list of genesets, for 
each method, using pairwise comparisons between the three datasets.  
Among all methods tested, FAERI provides the best correlated results between 
related datasets; regardless of the source of geneset definition used (each category 
of the MSIGDB10 was used for this purpose). FAERI thus outperforms all methods 
tested for its ability to attribute similar scores to each geneset from several datasets. 
 
Microarray noise issues 
One of the major difficulties in deciphering high throughput gene expression 
experiments comes from the noisy nature of the data.  
Microarray data are commonly perceived as being extremely noisy because of many 
imperfections inherent in the microarray technology (Barrett, et al., 2009).  
To correctly interpret the gene expression microarray data, it is crucial to understand 
the sources of the experimental noise. There are two principal sources of noise in 
microarray experiments: biological noise and technical noise. Biological noise consists 
of variation among patients and tumor locations, variation in the cellular composition 
of tumors, heterogeneity of the genetic material within tumor due to genomic 
instability.  
Technical noise consists of differences in sample preparation and experiment 
variables which include non-specific cross hybridization, differences in the efficiency 
of labeling reactions and production differences between microarrays.  
A recent study suggests that, contrary to popular belief, the random fluctuations of 
gene expression signals caused by technical noise are quite low and the effect of such 
                                                   
10
 Molecular Signatures Database, www.broadinstitute.org/gsea/msigdb/index.jsp 
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fluctuations on the results of statistical inference from Affymetrix  GeneChip 
microarray data is negligibly small (Klebanov and Yakovlev, 2007).  
If the noise is consistent and reproducible it can be filtered from the data and some 
false positives can be eliminated. The noise derived from microarray experimental 
techniques is reproducible and its boundaries can be modeled by statistical 
algorithms. However, biological noise cannot be completely corrected but it can be 
accounted for and reduced with statistical methods using replicates of the conditions 
or other approaches. 
This approach is often costly for many researchers and sometimes impossible for 
others given limited resources; thus, appropriate methods which increase accuracy at 
no additional cost, are needed. One inexpensive source of microarray replicates 
comes from prior studies: to date, data from hundreds of thousands of microarray 
experiments are stored in the public repositories. Although these data assay a wide 
range of conditions, they cannot be used directly to inform any particular experiment 
and are thus ignored by most differentially expressed gene methods.  
Another promising approach is the one we proposed in this research study.   
This approach consists of a tool that integrates biological information and combined 
microarray gene expression data, to reduce the background noise which limits the 
interpretation of microarrays experiments. 
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Thesis structure 
This thesis consists of a further six chapters structured and detailed as follows: 
Chapter II presents the genesis of this work (PathEx web tool background), context 
and motivation in the field of microarray analysis. We reviewed the position of the 
current research with respect to known near competitors.  
Chapter III detailed PathEx rationale, design steps, implementation and testing. 
Chapter IV covers PathEx results and critical assessment of PathEx by discussing its 
efficiency/effectiveness when applied to different partners published studies. Three 
validations (two on meta-analysis of metastasis and another on critical mediators of 
atopic dermatitis pathways) are discussed. 
Chapter V highlights further directions of current research, presenting a planned 
project of creating a broad microarray pipeline analysis tool comprising PathEx, 
Pegase11, FAERI and gVIz analysis tools.  It also discusses in details the development 
of gViz, a tool implemented with two-fold interest notably prediction and validation 
of gene groups via the use of annotation information from PathEx database 
component.  
Chapter VI discusses the main conclusions of this research by summarizing the work 
completed, by discussing how the research questions have been answered. Also, the 
contributions to knowledge achieved through the application of PathEx are discussed. 
The chapter rounds up with some final remarks. 
                                                   
11
 Pegase is an old version of FAERI method; in Pegase ANOVA-2 is not implemented. 
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Thesis genesis 
 
Aim of the study 
One of the objectives of microarray experiments is to identify genes that are 
differentially expressed in biological samples under different conditions (e.g., disease 
vs. control). The samples may come from tissues extracted from different organs or 
parts of the same organ (e.g., different brain regions). In this case, we may be able to 
discover differentially expressed genes in each organ/organ part and how disease 
may affect each organ/organ part at the gene expression level. 
Although there has been a trend whereby many researchers widely use microarray 
technologies, less is done computationally to interpret and validate biological 
hypotheses formulated from inherent investigation results. Continued microarray 
data deposit and revision of genome annotations are important to supplement 
previously submitted microarray metadata. While the advent of microarray 
technologies and an increasing number of analysis methods present an opportunity 
to better understand life mechanisms, exploitation of microarray data and the choice 
of analysis methods remain challenges.  
Also, considering that technologies like microarrays remain prohibitively expensive 
for researchers with limited means to order their own experimental chips, it would be 
beneficial to re-use previously published microarray data.  
For certain researchers interested in finding gene groups (requiring many replicates), 
there is a great need for tools to help them to select appropriately datasets for 
analysis. These tools may be effective, if and only if, they are able to re-use previously 
deposited experiments or to create new experiments not initially envisioned by the 
depositors. However, the generation of new experiments requires that all published 
microarray data be completely annotated, which is not currently the case.  
We present, in this thesis, a novel approach (PathEx) which, taking into consideration 
the above facts, has contributed to solve various issues related to microarray 
analysis. 
PathEx is, a human-focused web solution built around a two-component system: one 
database component, enriched with relevant biological information (expression 
array, omics data, literature) from different sources, and another component 
comprising sophisticated web interfaces that allow users to perform complex dataset 
building queries on the contents integrated into the PathEx database. 
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The idea behind the development of PathEx is three-fold: 
First, while conducting a benchmark of different microarray statistical analysis 
methods (De Hertogh, et al., 2010), it was found that some methods focusing on 
finding gene groups might require many replicates. For a researcher considering 
conducting a microarray analysis, one consideration should be taken into account: 
the dataset of interest. As single microarray dataset usually contains a large number 
of genes (hundreds or thousands) but the number of observations is much lower – 
generally tens or up to a few hundred at the very most; which makes it very difficult 
to extract reliable biological information from a single dataset. However, it only 
makes sense to combine data sets if the questions are the same, or, if some aspects 
of the experiments are sufficiently similar that one can hope to make better 
inference from the whole than from the experiments separately. Several studies have 
proved that combining data from multiple experimental studies can improve 
biological prediction results, even in the case where the scientific focus and 
experimental conditions of the individual microarray studies differ from one another 
(Zhu, et al., 2008) (Ivliev, et al., 2008) (Menssen, et al., 2009). 
Second, to use a combinational approach of enriched (with different types of 
biological information) microarray data from public microarray repositories to 
generate focused datasets. These specific datasets, which may be used in co-
expression analysis by organizing genes into different functional groups based on the 
principle that genes belonging to the same functional groups or pathways will have 
similar expression profiles over a range of experimental conditions. This is true 
because biologists often already knew a subset of genes involved in a specific genes 
group of interest (pathway, disease state…) and may wish to discover other genes 
that can be assigned to the same group. As such, the co-expression analysis 
approaches are more suitable. As such, supervised dataset selection algorithms will 
tend to assign group memberships to genes that correspond well to the true 
underlying biological phenomena. One major drawback of these approaches is that 
annotation is learned directly from the expression data without taking advantage of 
the often available predefined annotation information contained in different 
biological databases/databanks. As a result, co-expression analysis approaches can 
generate groups of genes that do not correspond well to the true underlying 
biological pathways. 
Third, features provided in this approach, allow it to generate any kind of datasets, 
with an added value of enriching their meta-data with biological annotations from 
different sources of biological data, reducing at the same time a portion of 
microarray data noise. The outcome tool integrates easily any statistical analysis 
pipeline tools.  
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State of the art 
We propose here a novel web tool that combines information from microarray data, 
the literature and “omics” technologies. Its main objective is to allow for 
instantaneous selection and generation of datasets of interest by drawing relevant 
samples files from major publicly available microarray repositories and using simple 
but biologically meaningful keywords to query the underlying database. PathEx 
provides biologists (with no or limited pre-knowledge of the structure and 
organization of the microarray data) with an intuitive web interface to generate 
datasets for validation of existing studies, discovery of new phenomena or 
complementation of hypotheses regarding phenomena only partially understood. 
Many researchers must often manually retrieve or use certain tools available to 
retrieve microarray data from public repositories. However, such tools are most often 
limited to pre-knowledge of the structures and formats of the deposited microarray 
data. 
Several tools proposed are mainly either retrieval tools (Microarray Retriever (MaRe) 
(Ivliev, et al., 2008)) or full integrated but manufacturer-oriented analysis tools 
(combining retrieval and analysis tools: EzArray (Zhu, et al., 2008) and SiPaGene 
(Menssen, et al., 2009)). 
However, none have the enhanced ability to allow researchers to automatically select 
data of interest by focusing on certain biological factors that were not necessarily 
those provided in the microarray metadata. 
Unlike existing tools, the power of PathEx is its fast processing capability made 
possible through local storage of all of the data (to avoid the sequential downloading 
policies and bandwidth limitation associated with most microarray repositories). 
PathEx also remains unique in that it acts as a point of integration of fully re-
organized information from public sources. Furthermore, PathEx is not bound to any 
microarray manufacturer or type. This allows for the datasets selected by PathEx to 
be analyzed by any platform associated analysis method.
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Design 
 
PathEx rationale  
As PathEx does not aim to be yet another microarray retrieval tool and the main goal 
was to develop a novel concept to offer less exploited opportunities for the analysis 
of deposited microarray data. Deposited microarray data comes with description files 
(though these files are sometimes incomplete). These metadata files do however 
contain some key information that can be used to link the microarray data to other 
biologically related information. We propose here a system that uses this 
identification metadata to link microarray data to other biological concepts such as 
Genes, Proteins, Metabolic Pathways and the Literature. By further characterizing 
previously deposited microarray data; we provide researchers with new 
opportunities to select interesting datasets by simply using meaningful biological 
criteria to query the underlying PathEx database.  
 
PathEx data sources 
In recent years, the number of biological data sources, and the quality and the 
quantity of information available to life sciences researchers have increased at a very 
fast rate. Such data sources are now essential to some of them with limited financial 
means. However, for computational tasks involving an answer to a biological 
question, researchers often spend much of time and effort to (a) manually use the 
interfaces of biological data sources, (b) extract and import data into their own 
environments, (c) relate various disconnected information found in the extracted 
data, (d) refine the search criteria, and (e) repeat the whole process from the 
beginning. 
Our goal is to provide with researchers an integrated web software system which 
accesses multiple biological data sources, integrates the retrieved data, and create 
knowledge to reduce noise emanating from raw microarray data. 
Mainly PathEx data comes from two categories of sources:  
1. Microarray data which come mostly from two major microarray repositories  
National Center for Biotechnology Gene Expression Omnibus (NCBI GEO) 
(Barrett and Edgar, 2006) and European Bioinformatics Institute Array Express 
(EBI AE) (Rocca-Serra, et al., 2003) (Brazma, et al., 2003) (Parkinson, et al., 
2005) (Parkinson, et al., 2007). 
2. Other biological information used to further characterize that microarray data 
is mainly taken from major omics databases/databanks. These data mainly 
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concern gene annotations from EntrezGene (Maglott, et al., 2005), Kyoto 
Encyclopedia of Gene and Genomes (KEGG) (Ogata, et al., 1999) (Kanehisa and 
Goto, 2000), ENSEMBL (Hubbard, et al., 2002) (Birney, et al., 2004) (Hubbard, 
et al., 2005) (Birney, et al., 2006) (Hubbard, et al., 2007) (Flicek, et al., 2008) 
(Hubbard, et al., 2009), H-InvDB (Yamasaki, et al., 2009), Vertebrate Genome 
Annotation (Vega) (Ashurst, et al., 2005) (Wilming, et al., 2008), protein 
information from UniProt/Swiss-Prot (Boeckmann, et al., 2003), ENSEMBL, 
metabolic pathway information from KEGG Pathways, disease information 
from OMIM (Rashbass, 1995) and literature from PubMed (Guillaume, 1998). 
The question is “How to effectively manage this huge and heterogeneous amount of 
data?” 
In this thesis, we step by step describe how PathEx has provided researchers with an 
effective web application of advanced data management technology to biological 
data. 
 
Biological data challenges 
Every day, a large amount of biological data is produced and need to be organized, 
queried and reduced to useful scientific knowledge.  Although  data  management  
technology can  provide  solutions  to  problems,  in  practice  the data   needs  of  
biomedical   research  are   not  well served and existing  data  management  
technology  is  often challenged  by  the  lack  of  stability,  evolving  nature, diversity     
and     implicit     scientific     context     that characterize biological data.   
Biological data are broad   and diverse.  Biology encompasses many domains of 
knowledge. Each of domains those is concerned with overlapping or complementary 
entity types, and has its own terminology   and data needs. Furthermore, the variety 
of experimental procedures yield   related   but   not   identical   data.  New  bio- 
analytical  procedures and  progress in  the  science add  another  dimension  of  
instability  to  biological data  types.   
Most of the information that the biological research is interested   in   is   available   in   
public   reference databases and specialized private data sources.  It is  estimated  
that  much  of the  biological  data  are  in text  form,  and  the  rest resides  in  
databases that range from indexed files, to relational and specialized formats.  
Biological databases  may contain  primary  data  i.e.,  have  their  own  data  entry or 
submission policy, or secondary data i.e., built by integrating data from primary 
sources in which case their  integrity depends on  the  constituent  sources. As many   
of these data   sources are   non-standard and not well documented, accessing, 
integrating and sharing biological data becomes a challenge and an art. 
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Biological data management 
A scientist may query a biological database, manually peruse the results of this query, 
find the data of interest, and use this data in a query of a second biological database. 
Performing manual multi-database queries of this sort can be a time-consuming 
process, especially when large amounts of data are involved, as is often the case in 
biological research. Therefore, a need exists for automated data integration from 
multiple databases. 
Data materialized integrations (materialized integration) and database federations 
(virtual integration) are two approaches that have been developed to deal with this 
data integration. In materialized integration, data are combined from multiple data 
sources into one large database that houses the data of the individual databases. 
Materialized integration, which includes data format conversions, is performed at the 
time of the data materialized integration creation. Queries are performed on this 
integrated data source. In virtual integration, software modules are created to 
interact with the databases included in the federation. Data integration is performed 
at run-time at the time of the query, since the data must be obtained on the fly from 
all the separate databases involved in the query. Both approaches have several 
advantages and drawbacks that will be discussed later. 
 
Integration issues related to biological data sources 
Managing and integrating biological data collected by scientists and researchers from 
around the world can be very challenging for various reasons (the quantity of 
biological data, the large number of biological databases, the rapid rate in the growth 
of biological data, the overabundance of data types and formats, the variety of data 
access techniques, database heterogeneity, errors in biological data, and even the 
interdisciplinary nature of the field of bioinformatics).  
 
Virtual integration or federation approach 
The federation approach (Figure 7) to integrating data from heterogeneous 
databases does not require the creation of a new giant database to hold transformed 
versions of the data from constituent databases as in the data materialized 
integration approach. Interoperability does not require global integration. It is 
possible to develop software that can operate on multiple databases without solving 
the much harder problem of [globally] integrating those databases. In the federation 
approach, individual data sources act in a completely autonomous fashion as if they 
are not part of the federation. The federation is dependent upon its constituent data 
sources, but the individual data sources are in no way dependent upon the 
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federation, since they may not even be aware of the existence of the federation. To 
emulate a single data source in the federation approach, one or two types of 
software component are often used: mediators and translators. 
A translator is responsible for tasks such as performing the data format conversions 
that are necessary for a particular source’s data to be used in a federation query. For 
instance, a source may contain data stored as objects, but the translator may convert 
this object data into a relational table to be used by the federation. A translator is 
useful for resolving certain types of heterogeneity such as value heterogeneity. 
A mediator makes a determination as to which data sources in the federation need to 
be involved via translators in a particular query. After translators return their results 
to the mediator, the mediator must perform integration of the data from the 
different sources. 
Mediator and translator updating can be accomplished in different ways. For 
example, certain knowledge or federation standards may be hard-coded into the 
software components. It is also possible to have a separate federation database 
dedicated to holding syntactic and semantic knowledge of the various databases 
involved in the federation, and changes to data in this data-dictionary-like database 
could be used to periodically update translators and mediators. Trigger-like 
mechanisms could be used so that changes to this database could automatically 
update the affected translators and mediators. The ability to save historic data in this 
database could be essential so that if problematic data changes cause some of the 
mediators and translators in the federation to malfunction, it could be possible to 
restore earlier working configurations. 
 
 
Figure 7 - Federation approach architecture 
In federation approach, each source is queried separately and snapshots of 
interesting information are mediated in a virtual view. 
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There are several advantages to the federation approach. Federations do not require 
a global schema as is the case in typical data materialized integrations. Federated 
databases only require partial integration. A federated database integrates a 
collection of local data source systems by supporting interoperability between pairs 
or collections of the local data sources rather than through a complete global 
schema. The upkeep of enormous data materialized integration with its involved, 
global transformation issues is avoided in the federation approach. This is an 
important issue as biological databases continue to grow in number and in content. A 
principal advantage of an integration scheme based on mediators is that it allows the 
individual data sources to operate autonomously, but to function collectively as a 
federation. However, data materialized integrations don’t actually impede the 
functions of their constituent databases, so in actuality data materialized integrations 
also allow constituent databases to function autonomously. In fact, federation 
queries and data retrieval are performed against autonomous databases. This is truly 
an advantage of federations, since they can perform queries against the original 
databases. Federations see data updates at run-time, so there is no delay from the 
time data enters a database to the time it is available to users, as is the case in data 
materialized integrations. 
However, federations have certain disadvantages relative to data materialized 
integrations. To begin with, since data format conversions need to be done at run-
time, federation query performance is slower. Additionally, queries must be 
performed against multiple data sources. For example, in case sources are databases, 
this can be a time-consuming operation, since a query may require a large cross-
database join, and this join would probably be performed at a mediator rather than 
in one of the constituent databases. Such a join would be much faster in the case of a 
single-site database like a data materialized integration. Issues such as this have been 
addressed in query optimization in distributed databases. For example, if one table in 
one database contained a million rows and another table in another database 
contained ten rows and a joint need to be performed, of course it would make more 
sense to perform the joint at the first site. In a federation, a mediator would probably 
perform the joint, which would be time-consuming. However, perhaps a mediator 
could work in conjunction with an existing DBMS to perform a joint by sending data 
from another database to that database so that the joint will be performed at one of 
the databases rather than in the mediator. 
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Materialized integration approach 
In the materialized approach (Figure 8) to data integration, data from individual data 
sources is usually transformed into a common format and then stored in a large 
single database called a data materialized integration. In this case, data materialized 
integration is a single database that is constructed by physically consolidating a 
collection of data sources into an integrated whole… Thus, a materialized integration 
transforms a set of heterogeneous database s into a single, homogeneous database, 
and data stored in this way can be queried using the standard query tools of the 
DBMS (database management systems). The transformation is performed by a set of 
translators, each of which must convert a data source to a form that is compatible 
with the materialized integration. This conversion process can be complex, because 
source heterogeneity can manifest itself in a number of different aspects. The various 
types of heterogeneity (value and semantic) and other issues must be confronted 
during this integration phase that occurs when the data materialized integration is 
constructed. 
Data materialized integrations are typically read-only, since they draw their data from 
existing biological databases and may do various data transformations and 
integration steps that make it impossible to write changes to the base databases via 
the data materialized integration. Writing data to the data materialized integration 
itself would not make sense since the data materialized integration is periodically 
updated from the base data sources and any data written to the data materialized 
integration would be lost when the data materialized integration was updated. 
To construct a data materialized integration, monitoring systems must be 
implemented on the local databases to actively detect changes to them, and to 
propagate the changes to the data materialized integration. These changes are 
transformed into updates to the data materialized integration by a data integrator 
subsystem. 
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Figure 8 - Warehouse approach architecture 
In this approach interesting information is imported, mediated and stored locally. 
 
  
The advantages of materialized integration are that queries can be executed rapidly 
because all the data are located in one place, and the end user sees a homogeneous, 
integrated data source. Its disadvantages are that the integration of updates and 
revisions from the data sources into the materialized integration can be difficult and 
time consuming.  
By contrast, the distributed approach makes updates available instantly.  
In addition, as the number and size of biological data sources increase, the 
warehousing approach may not be able to keep pace because it becomes more and 
more time consuming to build large materialized integrations and to keep them up to 
date.  
Moreover, the storage and computing resources required to maintain the 
materialized integration become increasingly expensive. The amount of knowledge 
required about local schemas, how to identify and resolve heterogeneity among the 
local schemas, and how changes to local schemas can be rejected by corresponding 
changes in the global schema are major problems with this approach because of the 
complexity of a global schema.  
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Integration efforts that depend on making local copies of data (possibly modified in a 
variety of ways) from other data sources must contend with a number of factors that 
will make their task increasingly difficult. Those factors including:  
1. a proliferation of independently administered biological databases containing 
relevant data;  
2. the absence of a clear domain boundary for data of interest to the potential 
users of such integrated data products (implying that there is no obvious limit 
to the set of course data sources that should be integrated);  
3. and the accelerating rate of data production that will preclude manual 
intervention in the integration process (implying that all the information 
required to cross-reference data from two or more source databases must be 
present in or derivable from, those data sources). 
 
 
PathEx integration approach 
Contrary to materialized or virtual approaches, PathEx is built on a hybrid approach 
which makes the underlying PathEx database be read/written since data changes 
(updates) are made directly to this database.  In this approach, we combined the 
advantages of both materialized and virtual integration approaches (Figure 9). PathEx 
combines the better of these two approaches and delivers a data integration 
platform that offers data federation as an integrated module. This made it easier, 
quicker, and cheaper to apply both data federation and data integration capabilities 
to different biological data challenge we encountered.  
In this approach, where only virtual approach is possible, data drawn by the 
mediators are captured, converted and stored into a PathEx standard format to be 
later used in the relational database. This is mainly applied on proprietary data such 
those from KEGG and Array Express. While a data source can be physically copied, 
appropriate integrators were developed and sources physically imported before any 
conversion. 
With this approach, we ended up with a single system, multipurpose environment 
PathEx, instead of multiple, independent tools, each with their own architecture, 
metadata, semantic model, and functionality.  
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Figure 9 - PathEx data integration approach architecture 
PathEx mixes the virtual and data warehouse approaches due to technical constraints 
and access limitation of some sources. 
 
 
PathEx system architecture 
The PathEx architecture is divided into three main components (Figure 10): The 
Processing Logic, The Contents Logic and The Navigator Logic. The Processing Logic 
has four interdependent utilities (Data Mining Utility, Integration Utility, Query 
Handler Utility and Updater Utility), The Contents Logic has two storage approaches 
(Database and Files Repository) and The Navigator Logic has several interfaces (Query 
Settings, Dataset Builder, Dataset Cart and Global Datasets Manager).  
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Figure 10 - PathEx system architecture 
 
PathEx data processing logic 
The PathEx Processing Logic is responsible for: 
1. Federation of: 
a. Basic microarray data (platforms, experiments and samples) and 
associated sample raw data from GEO Simple Omnibus Format in Text 
(SOFT, http://www.ncbi.nlm.nih.gov/geo/info/soft2.html#SOFTformat) 
files (Figure 11) and Array Express MicroArray (Figure 12) and Gene 
Expression tab (MAGE-TAB) (Rayner, et al., 2006)) files,  
b. Additional reviewed microarray metadata, not primarily envisioned by 
the experiment owners (biological tags: sex, tissue, organ) and   
c. Biological information (genes, proteins, metabolic pathways and 
literature information), 
2. Remote change tracking, monitoring and updating whenever required,  
3. PathEx user and query management and 
4. PathEx database integration. 
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Figure 11 - Example of a snapshop view result returned by a query to NCBI GEO (Source: http://www.ncbi.nlm.nih.gov/geo/) 
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Figure 12 - Example of a snapshop view result returned by a query to EBI ArrayExpress (Source: http://www.ebi.ac.uk/arrayexpress/) 
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As one of the back end components of PathEx, The Data Mining Utility provides a set 
of algorithms to extract, parse, organize, correlate and convert relevant information: 
Microarray data (e.g. .CEL files) and metadata, Genes, Proteins, Pathways and 
Literature information. The Integration Utility manages a relational database 
component by loading into and updating it with appropriate structured data. The 
Query Handler Utility that negotiates the dataset build by checking submitted 
selection criteria and filters and invoking necessary sample files to build a dataset 
handles all user queries. PathEx, through the Updater Utility, provides a schema-
evolution service that is valuable because the ongoing revision of biological data and 
the complexity of its database schemas imply that they are always evolving. 
 
PathEx content (storage) logic 
This component manages the PathEx data storage system: (a) the File Repositories of 
microarray data files: SOFT files (from GEO), MAGE-TAB files (from AE) and different 
biological source files used to enrich microarray characterization and (b) the 
Database containing structured and manually reviewed related microarray metadata 
and annotation information (pathway-related information, cellular components, 
molecular functions, disease-related information, literature information, gene-related 
information, protein related information, study types, etc.).  
GEO SOFT files contain data tables and the accompanying descriptive information for 
multiple, concatenated Platforms, Samples, and/or Series records. 
The integrated AE MAGE-TAB files consist of four different types of files: (a) A “raw” 
zip archive contains the raw data files, i.e. the files produced by the microarray image 
analysis software, such as CEL files for Affymetrix GeneChip, (b) The Array Design 
Format (ADF) tab-delimited file describes the design of an array, (c) The Investigation 
Description Format (IDF) tab-delimited file contains top-level information about the 
experiment including the title, description, submitter contact details and protocols 
and (d) The Sample and Data Relationship Format (SDRF) tab-delimited file containing 
the relationships between the samples and arrays, as well as sample properties and 
experimental factors, as provided by the data submitter. 
Although the vast majority of these data sources are imported and integrated 
automatically by appropriate computing tools (API, external connectors, etc.), a 
significant portion of PathEx integrated data were manually recorded by a 9-team 
members during 3 months. Beside this data recording process, a validation process 
was carried out on all data integrated into PathEx database. This validation process 
(done by the URBM bioinformatics research team members) consisted of drawing 
randomly 20% of all imported and integrated data, verifying them against their 
original sources and making sure that the original biological meaning is preserved 
retaining the simpler form in the database.   
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PathEx navigation (browsing) logic 
This component comprises a set of intuitive, interactive and easy-to-use web 
interfaces. They provide users with features to customize and select a dataset simply 
by specifying criteria not initially envisioned by those who deposited the expression 
array data. 
 
 
PathEx design pattern 
The purpose of most of biological web application/database systems is to retrieve 
data from a data source and display it for the researcher. Because the key flow of 
information is between the data source and the researcher interface, many 
developers might be inclined to tie these two pieces together to reduce the amount 
of coding and to improve application performance. However, this seemingly natural 
approach has some significant problems. One problem is that the user interface tends 
to change much more frequently than the data storage system.  
Another problem with coupling the data and user interface pieces is that biological 
applications tend to incorporate back-end logic that goes far beyond data 
transmission.  
The problem which rises in this case is: “How do we modularize the user interface 
functionality of PathEx so that we can easily modify the individual parts?” 
With PathEx, we tried to consider the following facts that act on a system within this 
context and which were reconciled as we considered a solution to the problem 
stated: 
 User interface logic tends to change more frequently than back-end logic, 
especially in Web-based applications. For example, new user interface pages 
may be added, or existing page layouts may be shuffled around. If 
presentation code and back-end logic are combined in a single object, one 
have to modify an object containing back-end logic every time the user 
interface changes. This is likely to introduce errors and require the retesting of 
all back-end logic after every minimal user interface change. 
 In some cases, the application displays the same data in different ways. In 
some rich-client user interfaces, multiple views of the same data are shown at 
the same time. If the user changes data in one view, the system must update 
all other views of the data automatically.  
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 Designing visually appealing and efficient web interfaces generally requires a 
different skill set than does developing complex back-end logic (e.g. designing 
a database underlying a web application). Rarely does a person have both skill 
sets. Therefore, it is desirable to separate the development effort of these two 
parts to allow effective development.  
 User interface activity generally consists of two parts: presentation and 
update. The presentation part retrieves data from a data source and formats 
the data for display. When the user performs an action based on the data, the 
update part passes control back to the back-end logic to update the data. 
 In many web applications, a single page request combines the processing of 
the action associated with the button/link that the user clicked/selected with 
the rendering of the target page. Sometimes, the target page may not be 
directly related to the action.  
 User interface code tends to be more device-dependent than back-end logic. If 
you want to move the application from a browser-based application to a PC-
based application, you must replace much of the user interface code, whereas 
the back-end logic may be unaffected. A clean separation of these two parts 
accelerates the migration and minimizes the risk of introducing errors into the 
back-end logic. 
 Creating automated tests for user interfaces is generally more difficult and 
time-consuming than creating those for back-end logic. Therefore, reducing 
the amount of code that is directly tied to the user interface enhances the 
testability of the application. 
 
How does PathEx solve this problem?  
In this research, we opted for the Model-View-Controller (MVC) pattern. This pattern 
separates the modeling of the database, the presentation, and the actions based on 
user input into three separate components (Burbeck, 1992):  
 Model. The model manages the behavior and data of the application database, 
responds to queries from researchers, and responds to instructions to change 
state (usually from the controller). 
 View. The view manages the display of query results.  
 Controller. The controller interprets the mouse and keyboard inputs from the 
user, informing the model and/or the view to change as appropriate.  
Figure 13 depicts the structural relationship between the three objects. 
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Figure 13 - MVC pattern abstraction (Source: http://www.enode.com/mvc.gif) 
 
It is important to note that both the view and the controller depend on the model. 
However, the model depends on neither the view nor the controller. This is one the 
key benefits of the separation. This separation allows the model to be built and 
tested independent of the visual presentation.  
In PathEx, we chose to use a passive variation of the MVC instead of an active one.  
The passive variation of the MVC is employed when one controller manipulates the 
model exclusively. The controller modifies the model and then informs the view that 
the model has changed and should be refreshed (see Figure 14). The model in this 
scenario is completely independent of the view and the controller, which means that 
there is no means for the model to report changes in its state. The browser displays 
the view and responds to user input, but it does not detect changes in the data on 
the server. Only when the user explicitly requests a refresh is the server interrogated 
for changes.  
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Figure 14 - Behavior of a passive MVC model (Source: http://i.msdn.microsoft.com/passive_mvc.gif ) 
 
The active model is used when the model changes state without the controller's 
involvement.  
However, one of the motivations of using the MVC pattern in PathEx is to make the 
model independent from of the views. If the model had to notify the views of 
changes, we would reintroduce the dependency we were looking to avoid.  
Another major advantage of using the MVC pattern is testability. Testing components 
becomes difficult when they are highly interdependent, especially with user interface 
components. These types of components often require a complex setup just to test a 
simple function. Worse, when an error occurs, it is hard to isolate the problem to a 
specific component. This is the reason why separation of concerns is such an 
important architectural driver. MVC separates the concern of storing, displaying, and 
updating data into three components that can be tested individually. 
MVC does not eliminate the need for user interface testing, but separating the model 
from the presentation logic allows the model to be tested independently from the 
presentation and reduces the number of user interface test cases. 
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Benefits gained by using MVC pattern  
 Supports multiple views. Because the view is separated from the model and 
there is no direct dependency from the model to the view, the user interface 
can display multiple views of the same data at the same time. Multiple pages 
in a Web application may use the same model objects. For example, currently, 
gViz (a co-expression networks visualization tool, developed in our lab, uses as 
well the same database as PathEx).  
 Accommodates change. User interface requirements tend to change more 
rapidly than back-end rules. Users may prefer different colors, fonts, screen 
layouts, and levels of support. Because the model does not depend on the 
views, adding new types of views to the system generally does not affect the 
model. As a result, the scope of change is confined to the view.  
 
Constraints associated to the MVC pattern 
 Complexity. The MVC pattern increases the complexity of PathEx solution 
slightly. It also increases the event-driven nature of the user-interface code, 
which can become more difficult to debug (PathEx Interface grid views are 
complex to understand). 
 Cost of frequent updates. Decoupling the model from the view does not mean 
that developers of the model can ignore the nature of the views. For example, 
if the model undergoes frequent changes, it could flood the views with update 
requests. Some views, such as graphical displays, may take some time to 
render. As a result, the view may fall behind update requests. Therefore, it is 
important to keep the view in mind when coding the model.  
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Implementation 
 
Technological choices 
There are many factors in consideration when you develop a web-based application. 
Some are hardware-related and other software-related. As the purpose of this thesis 
is not a comparative study on web development technologies, we limited our choice 
criteria on few factors. In fact, technological choices for web-based applications 
development are motivated by several factors such the audience, the purpose, the 
content and the development resources. 
 The audience. PathEx can be used by any researcher with or without limited 
knowledge on microarray technologies. It was implemented with the idea of 
minimizing the burden related to different biological sources integrated in it. 
 The Purpose. The primary purpose of PathEx is to generate study focused 
datasets, by providing to users a series of advanced query features. 
 The content. PathEx users do not need to have any pre-knowledge of data 
behind it. They are just to input key criteria of their choice. 
 The development resources. As one person-project, it was difficult to comply 
to all development standard requirements (source control, multiple checkouts 
and merge resolution) due to time constraints but we did it to ease a potential 
project takeover by a third party.  
 
 
Technical choices 
 
Hardware 
PathEx is hosted on a dedicated cluster of 20 nodes, each having 16GB RAM. The 
cluster manages a storage system of up to 40TB. In case of PathEx, hardware choices 
were also driven by other partners’ software requirements and university 
consolidated infrastructure support. In fact the cluster is currently integrated in a 
global computing cluster facility (iSCF) of the University of Namur. 
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Software 
Apart from the availability of hardware infrastructure of the University of Namur, 
some factors informed the choice of the software used in the development of PathEx.  
These include: 
1. Licensing. With the exception of some of the enterprise licensing options, a 
software bundle brings zero licensing fees to the table. Commercial products 
vendors charge for the OS, database server, any specialized servers your 
application requires, and their IDE.  
2. Support. Commercial products vendors will provide you with support, but 
again, it costs money. Free and Open Source Solutions comes with, in my 
opinion, a much more robust support option - the actual developers who 
worked on the project plus its community. Most of the time these products 
are free.  
3. Platform. You can setup the stack on a wide range of platforms, by combining 
effectively several software solutions. Currently the most popular is the 
software bundle LAMP, (L standing for Linux (http://www.linux.org/), 
operating system; A for Apache (http://www.apache.org/), the web server; M 
for MySQL (http://www.mysql.com/), the database management system and P 
for PHP (http://www.php.net/), Perl (http://www.perl.org/) or Python 
(http://www.linuxfoundation.org/), the scripting language).  
4. Hardware. This goes hand-in-hand with platform above. Linux can run very 
well on very inexpensive servers. It can do this because it provides 
administrators with the flexibility to run only what is needed to do the job. In 
commercial solutions, you are stuck with bloat - think how much resources 
needed, whereas it is typical to run headless Linux machines and use ssh to 
access a shell remotely. 
5. Performance. This is tied to hardware above. When compared to a commercial 
product server with the same specifications; a Linux server dominates the ring 
in terms of performance, memory management, stability, etc...  
6. Scalability. Scaling a web application is never cut and dry, but it is much more 
straight forward and cost-efficient when you're dealing with Linux-based tools. 
Many of today's highest-volume effective web applications are running a 
LAMP stack, from Facebook (http://www.facebook.com/) to Yahoo 
(http://www.yahoo.com/) to Google (http://www.google.com/).   
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Based on the above considerations and several readings, we chose the LAMP stack 
with RedHat-based linux OS, CentOS (www.centos.org), Apache Web server, MySQL 
database management system and PHP as the main scripting language . Choosing 
LAMP was the best way for me to gain control and power over PathEx application.  
Table 3 shows a comparison table of several Operating Systems in term of license, file 
system handling procedures and system security considerations.
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Table 3 - Comparison of major operating systems by operational license and general information 
Name Creator First public 
release 
Predecessor Latest stable 
version 
Latest 
release 
date 
Preferred license  
FreeBSD12 The FreeBSD 
Project 
1993 386BSD 8.2 2011 BSD / Free 
Linux13 Richard Stallman, 
Linus Torvalds, et 
al. 
1992 Unix, Minix Linux kernel 2.6.37; 
GNU C Library 2.11 
2011 GNU GPL, GNU LGPL and 
other licenses / Free 
Mac OS X 
Server14 
Apple Inc. 2001 NeXTStep / OPENSTEP / 
Rhapsody, Mac OS, UNIX 
10.6.4 2010 Proprietary / Commercial 
(APSL, GNU GPL, others) 
Solaris15  Sun 1992 SunOS 10 10/09 2008 CDDL / Free 
Windows Server 
(NT family)16 
Microsoft 1993 MS-DOS, OS/2, Windows 
3.x 
Windows Server 
2008 R2 (NT 
6.1.7600) 
2009 Proprietary / Commercial 
                                                   
12
 www.freebsd.org 
13
 www.linuxfoundation.org 
14
 www.apple.com 
15
 www.oracle.com/us/solaris/index.html 
16
 www.microsoft.com 
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Operating System: CentOS.  
In this project, we chose CentOS17 as the main cluster OS hosting PathEx and all other 
PathEx connecting applications. The main reasons being that CentOS is the most 
stable, secure, tested distribution for servers (Tables 3, 6,7). It is derived (almost 
completely, except for the logos and names) from Red Hat Enterprise Linux. RHEL 
goes through several rounds of quality control by Red Hat and it is the most reliable 
Linux distribution. CentOS is a free (no cost) derivation of RHEL. 
 
Web server: Apache. 
To our knowledge, Apache web server remains the only appropriate open source 
(and free) web server solution underlying many web applications. Its adaptability and 
customization features have made it by far the leading web server in the world when 
you consider stability and security (Table 4).  
 
 
 
 
                                                   
17
 www.centos.org 
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Table 4 - Comparison of different web servers by security issues and dynamic content management ability 
Server  Security Dynamic Content 
Basic 
access 
authentication 
Digest 
access 
authentication 
https CGI FastCGI Java 
Servlets 
PHP ASP.NET IPv6 
Apache18 HTTP 
Server  
Yes Yes Yes Yes Yes No Yes Yes, by 
modules  
Yes 
Apache Tomcat Yes Yes Yes Yes No Yes Yes No ? 
IBM19 HTTP 
Server 
Yes Yes Yes Yes Yes No Yes No Yes 
Internet 
Information 
Services 
Yes Yes Yes Yes Yes No Yes Yes Yes 
 
                                                   
18
 www.apache.org 
19
 www.ibm.com 
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Database: MySQL 
There is a wide range of database management systems (proprietary/commercial and 
open source/free). In this project, our database management system solution choice 
was constrained by budget implications, limiting our selection to open source and 
free solutions. 
By considering only free and open source alternatives, quality of software and 
developer community, our choice went with MySQL20. MySQL is far the most flexible 
due to its design and conception aspects. The fact that MySQL avails several storage 
engines (MyISAM, InnoDB, MariaDB, ndb-cluster,…) suitable to any kind of database-
based applications. 
Feature set, reliability and developer community of MySQL might be an over kill for 
simple web applications, but any critical application we want to develop, MySQL is 
the choice of database. However, we recently heard that MySQL might not remain an 
open-source project because MySQL AB Company (owner of MySQL products) has 
been bought by Sun Microsystems which in turn were bought by Oracle Company. 
This pushes us to consider alternative but still interesting database management 
solutions such PostGreSQL. 
 
Server-side Scripting: PHP 
There are many equally appealing choices for scripting. Being a web application, we 
went with PHP21. Since this scripting programming language is made for web 
development with its version 5 Object Oriented Programming features; it has become 
a serious development language. 
Additionally, a set of increasing open source PHP classes and functions availed by PHP 
developers community is another factor put in consideration while choosing PHP as 
the main PathEx scripting language. 
 
JavaScript & CSS: JQuery 
Among the most promising web development solutions (which can easily be 
integrated into and combined with PHP), JavaScript and CSS are the major ones. 
                                                   
20
 www.mysql.com 
21
 www.php.net 
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Although JavaScript and CSS are not supported uniformly across browsers, it is useful 
to go with a framework to handle this.  
For JavaScript, the undisputed leading choice is JQuery (http://www.jquery.com/) 
which has taken the web development community by storm within a short period. 
Today it is the JavaScript framework of choice. It supports all browsers and makes 
JavaScript development organized and productive. 
 
 
Implementation strategies 
To implement PathEx, we considered first the “System Evolution” aspect. Any 
bioinformatics project being subject to constant evolution due to various reasons 
(continuous discoveries, updates and new needs), we have made sure that PathEx 
update procedures are well planned and carried out without PathEx service 
interruption. This has been achieved by adopting the MVC pattern in designing 
PathEx.  
The strategies followed to achieve this were to separate implementation into 3 
corresponding processes: The presentation (view) process, the data (model) process 
and the build (control) process.  Each of the three processes has several functions. 
The build process is somehow complex as it has three sub-processes: query sub-
process, dataset builder sub-process and migration and synchronization sub-process. 
 
PathEx Processes list 
PathEx is built around a series of PHP classes, the main being PathExGrid (Table 5) 
and a series of JavaScript Functions (Table 8). 
We took advantage of PHP Object Oriented programming features to lay down a 
series of reusable classes (which may be exported and exploited even in other PHP-
based applications). Naming conventions of classes have been followed and a touch 
of appending self-explanatory names has been used, to allow any developer a simple 
identification of codes. 
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Table 5 - PathEx core class properties 
PathEx PHP Grid Class 
Properties  Description 
AjaxEnabled Enable ajax feature of PathExGrid. 
AjaxHandlePage Get or set the service page which PathExGrid will send ajax 
request. 
AllowFiltering When true, all columns in grid will enable filtering feature. 
AllowGrouping When true, all columns in grid will enable grouping feature. 
AllowHovering Allow row highlighted when mouse is over. 
AllowMultiSelecting Allow selecting more than one row. 
AllowResizing When true, all resizable columns in grid will enable resizing 
feature. 
AllowScrolling Allow all tableview in grid scrollable. 
AllowSelecting Allow row selected 
AllowSorting When true, all sortable columns in grid will enable sorting 
feature. 
AutoGenerateColumns When true, grid will generate and add data-driven columns to all 
tableviews automatically. 
AutoGenerateDeleteC
olumn 
When true, grid will add delete command column to all 
tableviews automatically. 
AutoGenerateEditColu
mn 
When true, grid will add edit command column to all tableviews 
automatically. 
AutoGenerateExpandC
olumn 
When true, grid will add GridExpandDetailColumn to all 
tableviews automatically. 
AutoGenerateRowSele
ctColumn 
When true, grid will add GridRowSelectColumn to all tableviews 
automatically. 
CharSet Get or set the charset. 
ClientSettings Contain settings for client behaviours and messages. 
ColumnAlign Get or set alignment of column's text 
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ColumnValign Get or set vertical alignment of column's text 
ColumnWrap When true, all columns in grid will be in wrap mode. 
DataSource Get or set default datasource for all tableviews. 
DisableAutoGenerateD
ataFields 
Get or set the list of field names that will not be generated 
column by PathExGrid. 
EventHandler Get or set the object to handle grid events. 
FilterOptions Get or set default filter options for all columns in grid. 
Height Get or set detfault height of all tableviews. 
KeepSelectedRecords When true, grid will keep selected records persistent againts 
postback or callback. 
KeepViewStateInSessi
on 
Make grid persistent in session. 
MasterTable Master table object. 
PageSize Get or set the default page size for tableviews. 
RowAlternative When true, it makes grid show alternative color for each row. 
scriptFolder Get or set the path to folder which contains PathExGrid script. 
ShowFooter When true, it makes footer of all tableviews visible. 
ShowHeader When true, it make header of all tableviews visible. 
ShowStatus When true, grid will show the status bar at bottom of grid. 
styleFolder Get or set the folder which PathExGrid will load css to render. 
TableLayout Get or set layout of all tableviews. 
Width Get or set detfault width of all tableviews.  
Not only are above PHP classes encompass PathEx application, but also they are the 
core components of the gridding approach used to develop PathEx interfaces. This 
approach minimizes substantially the number of standard dynamic pages which 
would be required to achieve the same. 
As we could not list all PathEx classes, we limited our listing to the core ones. 
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Pathex data models 
Among all data modeling tasks, modeling biological data remains one of the most 
difficult tasks as earlier discussed on Biological Data Challenges Section. There exist 
three levels of data modeling: conceptual, logical and physical. The modeling 
complexity increases from conceptual to logical to physical. When modeling PathEx 
database, we started with the conceptual data model. This enable us to understand 
at high level what the different entities in our data were and how they related to one 
another. Then we moved on to the logical data model to understand the details of 
our data without worrying about how they would be implemented. Finally we ended 
with the physical data model which led to knowledge about the exact 
implementation of our data model in MySQL. In PathEx project, we noticed that the 
conceptual data model and the logical data model can be considered as a single 
deliverable due to the way it integrates various data sources. 
 
Conceptual modeling 
The following illustration (Figure 15) purely documents the data and information 
within the whole PathEx system and how it is used. It identifies the highest-level 
relationships between the different PathEx database component entities. At this level 
of modeling no attribute was specified and primary keys were specified. 
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Conceptual Diagram 
 
Figure 15 – PathEx Conceptual Data Model 
This model identifies the highest-level relationships between the different PathEx entities. 
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Inherent Enhanced Entity Relational (EER) diagram 
 
Figure 16 – PathEx Enhanced Entity Relation model 
The PathEx conceptual model (earlier discussed) depicted high-level relationship and had to be translated into an inherent Entity 
Relation (ER) model. However, we came to notice that a simpler ER model diagram does not reflect all key elements from the 
conceptual model diagram. We ended up by proposing a new type of ER model diagram, namely the Enhanced ER model diagram 
(Figure 16) 
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Logical modeling 
The advantage of laying out of this type of modeling on PathEx, is that it focused to 
the aim of creating a data model that is completely independent from any particular 
DBMS or software/hardware platform and is directed derived from the PathEx 
conceptual model.  
This model describes the PathEx data in as much detail as possible, without regard to 
how they will be physically implemented in the database. Features of a logical data 
model include: 
 All PathEx entities and relationships among them. 
 All attributes for each entity are specified. 
 The primary key for each entity is specified. 
 Foreign keys (keys identifying the relationship between different entities) are 
specified. 
 Normalization occurs at this level. 
There are different logical model notations. Even if we modeled PathEx by ER-Merise 
method, we thought it might be interesting to show the Baker logical model notation 
as well (Figure 17).  
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PathEx logical diagram 
Baker Model Option 
 
Figure 17 – PathEx Logical Data Model (Baker notation) 
This model describes the PathEx data in as much detail as possible, without regard to how they will be physically implemented. 
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ER- Merise Model Option 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This model lists out all PathEx tables and their respective fields. Some developers prefer this kind of model in place of graphical ones 
gene_entry (gid) 
gene (id, chromosome, gene_name, gene_symbol, #organism_id) 
pathway_entry (pid) 
pathway (path_id, path_name) 
organism (organism_id, organism_name) 
data_source (source_id, source_code, source_name, source_data_type, #pid, #gid) 
samples (sm, sm_title, sm_status, sm_sub_date, sm_upd_date, sm_type, sm_source1, 
sm_source2, sm_description, sm_row_count, sm_count_channel, #organism_id) 
pubmed (pubmed_id) 
series (se, se_title, se_status, se_sub_date, se_upd_date, se_type, se_summary, #pubmed_id) 
platforms (pl, pl_title, pl_sub_date, pl_upd_date, pl_distribution, pl_technology, 
pl_manufacturer) 
omim (omim_number) 
pathway2gene (path_id, id, p2g_id) 
gene_xref (gid, id, gx_id, prim_id, sec_id) 
pathway_xref (pid, path_id, px_id, pprim_id, psec_id) 
pathway2pubmed (path_id, pubmed_id, p2p_id) 
series2sample (se, sm, s2s_id) 
platform2sample (sm, pl, p2s_id) 
gene2pubmed (id, pubmed_id, g2p_id) 
omim2gene (omim_number, id, o2g_id) 
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Physical Modeling 
This model (Figure 18) represents how the model is built in the PathEx database. It 
shows all table structures, including column name, column data type, column 
constraints, primary key, foreign key, and relationships between tables in MySQL.  
Its main features include: 
 Specification all PathEx tables and columns. 
 Foreign keys are used to identify relationships between PathEx tables. 
 Denormalization. 
On this step, we turned previous PathEx models into DBMS (MySQL) instructions. At 
this level, since all other models have been well planned and analyzed, the remaining 
tasks were to: 
 Convert PathEx database component entities into MySQL tables. 
 Convert PathEx database component relationships into foreign keys. 
 Convert PathEx database component attributes into columns. 
 Modify the PDM based on physical constraints / requirements (e.g. MySQL 
storage engines: MyISAM, InnoDB, MariaDB…).  
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PathEx Physical Diagram 
 
 
Figure 18 – PathEx Physical Data Model 
This model represents how the PathEx model will be built in the MySQL database. It shows all table structures, including column 
name, column data type, column constraints, primary key, foreign key, and relationships between tables. 
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Pathex coding & features 
 
User interfaces coding  
PathEx web interfaces were coded using rich-client API, with many features topped 
with an unbeatable performance core API named PathExGrid. This API contains built-
in explorer-like navigator and several advanced features. 
 
Figure 19 - PathEx grid class features. 
 
PathExGrid key features (e.g. Figure 19): 
 Very easy to use, 
 Rich client-side API and events, 
 AJAX Capability, 
 State persistence through postback and ajax callback, 
 Scrolling with position persistence, 
 Sorting, Filtering, Grouping, Row (Multi)Selecting (Figure 20) 
 Full (De)Selecting (Figure 21) 
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Figure 20 - PathEx sorting, filtering, grouping, row multi (selecting) features 
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Figure 21 - PathEx full (de)select features 
PathEx contains a full-featured dataset builder and experiments/samples search and browse tool. Users can browse expression data 
(platforms, experiments and samples), set the viewing options, perform advanced searches, select platforms/experiments/samples 
of interest, set the dataset(s) building options, build dataset(s) and download new generated dataset(s). 
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Figure 22 - PathEx datasets builder ticketing system 
PathEx presents online directly. Each job request is associated to his/her owner and is assigned a ticket (Figure 22) identification 
code. The resulting files are compressed in one ZIP file (Figure 23) that can be retrieved any time for further use, each user having its 
own dedicated work environment. 
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Figure 23 - PathEx dataset cart interface 
On demand, an advanced job interface can be availed. This interface helps those who may wish to organize their datasets 
environment be creating new folders and files, merge, copy, rename or delete existing folders and files (Figure 24). We did not avail 
this interface to everyone due to storage issue. 
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Figure 24 - PathEx advanced dataset cart interface 
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Back-end coding 
PathEx back end utilities were coded using Perl, Java and Bash. The migration and 
synchronization tools were all coded in Perl while the dataset building tools were 
coded in Bash. 
The following (Figure 25) is an example of back-end snapshot Java codes. 
 
Figure 25 - Snapshot of datasets builder system Java codes 
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PathEx Update Issues 
Most of the biological sources integrated in PathEx keep on changing their data 
structures (models and format) and query interfaces (web, API…). Equally, some 
information used to annotate microarray metadata contained in PathEx were 
collected, reviewed and encoded manually.  
This aspect has hampered automation of PathEx update procedures and has made 
almost mandatory to have a staff keeping on adapting migration and synchronization 
update scripts.  
The fact that PathEx was developed also as a thesis project does not simplify the 
evolution and sustainability of this web solution.  
In this context, we developed a parallel update system allowing any non-
bioinformatician researcher (but with little pre-knowledge in bioinformatics) to 
encode manually updates and let PathEx take over remain update tasks.  
However, we wish to emphasis that this can only be a temporary solution as it is 
better to have a full automated solution as PathEx was intended in its initial status. 
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Results & Application on real cases 
 
Results 
Successful functional annotation of microarray data can lead to information useful for 
the elucidation of molecular mechanisms underlying various biological phenomena. It 
is therefore important to improve on the analysis of experimental gene expression 
data.  
Microarrays are the major source of data for gene expression levels, allowing the 
expression of thousands of genes to be measured simultaneously. There are now 
many publicly available microarray datasets under different experimental conditions. 
However, a key issue with microarray datasets is often referred to as the curse of 
dimensionality. A single microarray dataset usually contains a large number of genes 
(hundreds or thousands) but the number of observations is much lower - generally 
tens or up to a few hundred at the very most. This makes it very difficult to extract 
reliable biological information from a single dataset. 
Our research work addressed this need, enhancing data analysis performance in the 
functional annotation of genes by combining multiple microarray studies, using data 
resources that are increasingly common to scientists. 
It is not uncommon that experiments on identical or similar sets of genes are 
conducted by multiple laboratories for various functional studies of these genes. 
Much of such data are often available to researchers for their data analysis, either 
through collaborators or from online gene expression databases. It will be useful to 
combine data from different microarray studies to improve the microarray data 
analysis results. 
Integration of datasets increases the sample size and improves the analytical 
accuracy and statistical power of the test. 
However, blindly combining all available datasets may not always improve the 
analysis results. It is important to be selective of the datasets for inclusion. One of the 
most pressing challenges in the field of microarray technology is how to integrate 
results from different microarray experiments or combine data sets prior to the 
specific analysis. Proposed method is simple but useful to combine several data sets 
from different experimental conditions. With this method, biologically useful 
information can be detectable by applying various analytic methods to the combined 
datasets with increased sample size. 
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An inescapable problem with combining several microarray data sets is the variation 
of expressions between data sets. In cases where the microarray analyses are from 
different experimental conditions, integration without transformation may skew the 
expression ratios of the same genes from different data sets. When the experimental 
bias exceeds biological variation, the use of microarray data sets without adjustments 
for this bias may make biological variation unidentifiable, meaning that reliable 
results cannot be obtained. In addition, due to the limited numbers of available 
microarray experiments, the motivation to use the whole dataset, regardless of 
platforms or experimental procedure, is increasing. 
In this work, we showed our intuition that combining data from multiple 
experimental studies can improve microarray statistical data analysis results is 
correct, even in the cases where the scientific focus and experimental conditions of 
the individual microarray studies differ from one another.  
We know that to conduct a routine microarray study analysis, we need (a) a dataset 
of interest, (b) an appropriate analysis method and (c) a means to evaluate, interpret 
and validate the results obtained. Currently, benchmarking studies have often 
emphasized the importance of selection of the analysis methods. This agrees with our 
recent benchmarking analysis, where we showed that the choice of appropriate 
analysis methods is crucial for the accuracy of the expected results. Recently, a re-
analysis conducted on Golden Spike data by Pearson (Pearson, 2008) outlined the 
characteristics of an ideal dataset: (a) a realistic spike-in concentration, (b) a mixture 
of up- and down-regulated genes, (c) unrelated fold change and intensity and (d) a 
large number of arrays. Based on these criteria, we believe that custom selection of a 
dataset to analyze is crucial.  
As the principal objective of a microarray analysis is to reduce variability, we should 
consider unexploited ways to do this, particularly in light of the outcome of several 
studies (De Hertogh, et al.) that postulated a complex relationship between variability 
and expression level. We think that, without minimizing other sources, variability can 
be reduced by intelligently selecting a focused dataset (e.g. dataset related to a 
specific pathway, pathology, organ and other factors) 
However, as there are no existing tools to automatically select such a dataset, PathEx 
constitutes an important tool in this context.  
With its enriched content and advanced selection features, PathEx provides simple 
and easy-to-use interfaces (Figures 21, 22, 23, 24, 26) to help users avoid the burden 
of thinking about complex queries. It combines flexibility, fast processing, accuracy 
and an easy-to-understand search system using biological tag criteria. 
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Figure 26 – (A) the entrance page after login, (B) the query interface to (Multi) select experiments of interest, (C) the dataset-to-include samples setting interface (D) the dataset-to-create 
ticket code and (E) the user-driven dataset cart.  
With its multiple level consecutive query interfaces, PathEx maximizes the user searching process and keeps users informed of each 
query task filter output at each level of dataset selection within an interactive grid. 
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A user is provided with a specific area and interfaces according to settings chosen on 
the entrance page.  
PathEx provides three-level selection interfaces, related consecutively on the 
organizational levels of the microarray data (platforms, studies and samples). Besides 
a search area, coupled with a set of filters (“equals”, “contain”, “does not contain” 
and others) at each level to allow for criteria-driven selection of datasets, there are 
advanced features to ease selection such as grouping, sorting and multiselecting.  
Through the navigational settings, the user specifies the kind of keywords to query 
PathEx, to allow PathEx to display a customized interface. This approach was chosen 
to ease dataset selection and present clear interfaces.  
Many keyword types can be used to query PathEx (e.g. Accessions: gene IDs, gene 
symbols, protein IDs, OMIM number, and PubMed IDs; Factors: Metabolic pathway 
names, pathology names, tissues, and organ and experiment types). 
For each dataset selection request, a user is given a building ticket to trace the job 
process and download it when finished. The outcome is a compressed file containing 
all samples files related to the criteria submitted. 
There are two ways of retrieving the datasets generated. Any user may retrieve its 
own datasets through the job cart, as it is name-driven. To evaluate the performance 
of PathEx, we tested it by selecting a customized dataset related to “lung cancer” 
from “all” “GEO” experiments of the type “Affymetrix” GeneChip “HG-U133A”. By 
submitting the five highlighted search keys to PathEx and applying appropriate filters, 
we ended up, in less than 30 seconds, with a dataset of 108 samples. By cross-
checking we found that no any samples are related to lung cancer. Fact which 
confirms that PathEx was able to find expected samples 100% accurately. 
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Application on real cases 
Due to rapid advances of microarray data analysis technologies and specialized foci of 
previous microarray researchers, it will be of significance to re-analyze some 
published microarray data. In addition, with PathEx, it becomes possible to study 
some new research projects using deposited microarray data from different 
laboratories. 
We validated the PathEx efficiency by applying it to a real known biological 
phenomenon case, and further tested its retrieval ability by retrieving previously 
published expression data from two recently published studies. 
 
Case Study: Meta-analysis on Genes regulated by Hypoxia and 
involved in a metastatic phenotype in cancer cells. 
In a recently published work (Pierre, et al., 2010) (in which the author of this thesis 
contributed), we tried to evaluate the effectiveness of PathEx. We used it to try to 
find genes involved in the metastasis of cancer cells induced by hypoxia. Though 
many advances have been made in this field, all of the mechanisms involved are still 
not well understood. It is known that the expression of specific genes is modified in 
primary tumor cells to detach, migrate and invade surrounding tissues. But the 
integration of all of the associated data is a problem. 
We approached the principal investigator of this research, and we asked him to 
provide us with keywords he thought were matching his datasets. He provided us 
with the following keywords: metastasis, hypoxia, prostate and blastoma. We 
worked together to search and build a new dataset using the keywords he provided 
with. Knowing that he was interested mainly by Affymetrix GeneChip, we started by 
selecting platform by using keywords Affymetrix GeneChip, then we processed 
queries further.  
In the first phase of meta-analysis, we used PathEx to select datasets about 
metastasis, hypoxia, prostate and blastoma. Out of the seventeen (17) manually 
(Table 14) retrieved datasets (during three months), thirteen (13) were retrieved in 
less than five (5) minutes and four (4) were not retrieved at all. As some of the 
selected datasets were not available in GEO or AE, we investigated why PathEx could 
not find them. We came to notice that three (3) out of four (4) not retrieved were 
proprietary datasets (not available for the public directly, and PathEx does not index 
proprietary experiment datasets). The remaining dataset does not have any direct or 
indirect relation with the provided keywords. By trying to understand why, we 
noticed that during the manual review and curation processes, wrong information 
were recorded by errors. However this has been corrected as a second proof-review 
was conducted by different bioinformatics ‘team researchers.  
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After retrieving the above mentioned datasets, we decided to re-analyze them using 
the same methods as the one used in the original work. The surprise comes by 
noticing that results did not change. 
 
Below (Figure 27, 28 and 29) are some snapshots of the datasets building processes.
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Figure 27 - Search results by "metastasis" keyword. 
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Figure 28 - Search results by "hypoxia" keyword. 
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Figure 29 - Search results by "prostate" keyword. 
In the second phase, we again used PathEx to generate 14 customized meta-datasets from the 17 original datasets (Table 15).
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As we were able to find instantly all datasets initially retrieved manually during three 
(3) months, we were quite sure that the analysis would highlight as it did previously 
183 genes of interest (Figure 30). Out of these genes (in red on the figure), 99 were 
already known in the literature to be involved in cancer, among which 39 in 
metastasis, while 21 are related to the response to hypoxia. The other genes of 
interest found by our methodology are now under investigation to determine their 
role in hypoxia-induced metastasis. 
 
 
 
Figure 30 - Venn's diagram of interesting DE genes as revealed by the case study. 
The 22 datasets (or sub-datasets) were used to build several combinations in order to 
run intersections, union intersections and meta-analyses. These three approaches 
provided 704, 269 and 406 genes respectively. 
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To validate PathEx, we thought it may be useful to test additionally the PathEx 
retrieval accuracy and ability. On this step, we considered two published studies, 
which we knew exactly the datasets initially used to conduct analyses. 
In the first study aimed to highlights genes involved in metastasis from Several 
microarray datasets (Pierre, et al., 2011), the authors presented a new meta-analysis 
based methodology to pick out genes involved in one or two biological processes 
from several microarray datasets using a statistic that avoids the definition of an 
arbitrary threshold, providing statistically-significant results.  
As we knew the list of the datasets the used, we searched PathEx using “metastasis” 
keyword and found exactly the same datasets as the one used in the study (Figure 
31). 
The specificity of the above two proofing stages is that they were both somehow 
linked to our research and we did collaborate in them at some extent. The only way 
to test PathEx capability beyond the studies in which we participated (to avoid) bias, 
was to make sure that our approach work on third party studies.  
We tested again PathEx to see if it can retrieve dataset used in a study on 
“Transcriptional Profiling after Lipid Raft Disruption in Keratinocytes Identifies Critical 
Mediators of Atopic Dermatitis Pathways” (connie et al.). To do so, we queried 
PathEx by Pathways Search with keyword “Dermatitis” and we found exactly the 
same dataset as the original one submitted to GEO in April 2010 by the authors 
(Figure 32). 
After this validation, we think PathEx will be useful for researchers using microarrays, 
as it will help them to retrieve accurately and in less time datasets specific to their 
research of interest. PathEx will also provide users with opportunities to re-analyze 
previously published data by using new analysis methods hoping to unravel new 
biological phenomena which were not envisioned by the data depositors initially.
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Figure 31 - Pancreatic cancer dataset used to validate the research. 
By providing the keyword “metastasis”, PathEx was able to find the exact datasets used in the “Enhanced Meta-analysis study”. 
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Figure 32 – The dataset used in the Dermatitis study can easily be retrieved by using PathEx. 
The single dataset used in the study conducted by Connie in her study was drawn by PathEx by just providing keyword 
“dermatitisis”.
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Additionally, a recent study re-analyzed Atopic Dermatitis previously deposited data 
(Anne Laure & al., submitted). The study aims to identify new candidate genes 
involved in the AD pathogenesis and that are also deregulated in MβCD-treated 
kerationcytes. Several studies have previously demonstrated that Filaggrin, 
associated with the epidermal barrier structure, is the most important AD 
susceptibility gene identified to date. Some other candidate genes have been 
identified to be linked to either the epidermal barrier function or the immune system. 
 
Resulting paper 
In this thesis, we reviewed a series of existing microarray analytic methods and 
approach for filtering technical noise hampering microarray data statistical analysis. 
We also presented a novel approach for filtering technical noise, which by combing 
microarray data drawn from major repositories with biological annotation 
information from different sources proved to be effective compared to conventional 
statistical methods. 
The proposed solution improves microarray data statistical analysis by providing with 
users special features to select focused (study-oriented) datasets for further analysis. 
The outcome of this approach has been submitted and published as a database issue 
article in BMC Bioinformatics as shown in the following article manuscript.  
The originality of this tool (no such tool exists) made it accepted unanimously by all 
reviewers without revision requests (except 1 citation we were requested to add). 
The first reviewer finds combining the data from both repositories is a nice 
convenience feature. He has also found the query interface slick and fairly easy to use 
and he thinks that the article findings are important to those with closely related 
research interests.  
The second reviewer have noticed that PathEx fills a nice gap to get more information 
between published or by public database container like NCBI GEO or Array Express 
compared to biochemical analysis tools like KEGG and DAVID to find more 
information about increased or decreased comparison genes acting in different 
pathways. 
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PathEx: A novel multi factors based datasets selector web tool 
(as published in BMC Bioinformatics 2010, 11:528doi:10.1186/1471-2105-11-528) 
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Discussions 
In this research study, we present PathEx, a database-principled method for 
integrating pre-existing biological knowledge with microarray datasets from two 
major public microarray repositories into a single relational database. From prior 
knowledge, PathEx extracts “dataset’s metadata keywords” and linked biological 
annotations, which collectively constitute the datasets in consideration new 
descriptions (metadata). These dependencies are combined with the datasets to form 
the PathEx database, which enables expression information to be grouped in novel 
biologically related datasets capable of predicting and/or validating new biological 
phenomenon knowledge. 
To validate PathEx, we first tested that using random keywords, it was able to find 
and group all "provided keywords" related datasets exactly in less than 3 minutes. 
This result, would have taken not less than 3 months when done manually by simply 
retrieving datasets directly from GEO and ArrayExpress and reading different related 
literature. However, it was noticed that the use of PathEx should be done with 
caution as all datasets from GEO and ArrayExpress are heterogeneous in term of 
research laboratories where they have been conducted, experimental conditions and 
other factors linked to the datasets producers. 
We demonstrated PathEx performance, by using a real, in selecting right datasets on 
a research study we had initially published (Pierre, et al.) and where we spent almost 
six months building the datasets of interest. We noticed that our approach 
performed well while retrieving and instantly building the used datasets and 
metadata sets. 
Then, we further proved that PathEx outperforms major public microarray 
repositories as it helped us selecting (accurately) and building cancer related 
metadata sets used to carry out an enhanced meta-analysis (“Enhanced Meta-
analysis highlights genes involved in metastasis from several microarray datasets”, 
Journal of Proteomics Bioinformatics, volume 4, issue 2, pp. 36-43) in less than 3 
minutes, for a task which took manually three (3) months to complete. 
We, finally, evaluated PathEx ability to retrieve accurate datasets on "Dermatitis" 
study (“Transcriptional profiling after lipid raft disruption in keratinocytes identifies 
critical mediators of atopic dermatitis pathways”, Journal of Investigative 
Dermatology, volume 131, pp. 46-58), which was not at all related to our research 
laboratory.  
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A closer look at the functionalities PathEx system shows no similarity to other existing 
tools and repositories, including GEO and ArrayExpress. The difference between all 
these tools lies in their features for further encoding previously published microarray 
datasets, retrieving them instantly and generating novel biologically relevant 
datasets. Practically, the running time of PathEx is approximately less than twenty 
(20) minutes for the big metadata sets which may exist. 
Use of PathEx, however, does require some explicit assumptions about microarray 
knowledge and some cautions. First, we assume that existing microarray datasets 
contained in GEO and ArrayExpress were fully and correctly described (annotated). 
Second, we assume the users have a minimum knowledge on microarray data and 
methods. Third and finally, issues related to some methods such meta-analysis must 
be taken into consideration before selecting and building metadata sets for any 
meta-analysis. 
The provided PathEx web application is accessible at http://urbm-
cluster.urbm.fundp.ac.be/webapps/pathex. This application includes all necessary 
functions to test the approach along with several enriched datasets of the Affymetrix 
platforms type. Given its abilities to improve the rapid and performing retrieval of 
biologically related datasets, we expect that PathEx will be useful to microarray 
researchers studying and interpreting (predicting and validating) a wide range of 
biological phenomena. 
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Future directions 
As discussed in the introduction part of this thesis, microarray data noise occurs at 
different levels and different proportions. We know that several analytical methods 
have been proposed to reduce noise from microarray data. However as we 
demonstrated all along previous chapters, there are other approaches which can be 
applied to reduce noise using new data annotation systems based on enhanced 
biological knowledge. This approach being the rationale behind the papers presented 
in this thesis, proved to be enough effective to improve data retrieval by focusing on 
particular factor (experiment type, literature, disease, pathway…). The question at 
this level is “Do PathEx and gViz provide the ultimate solution to all noise issues in 
microarrays?” The response to this question is quite obvious: “No”. Considered alone, 
PathEx and gViz can somehow be used to reduce noise but, other analytical methods 
will still be required to significantly reduce microarray data noise.  
It is in this vision; we have started integrating different level bioinformatics’ solutions 
to come up with one integrated analysis solution (Figure 36). This new global analysis 
tool will encompass PathEx as an intelligent dataset generator, DAVID (Dennis, et al., 
2003) and PHOENIX (Fabrice Berger, et al., 2009) (for differential analysis) as analysis 
tool solution (by replacing its data management component by PathEx, the reason 
here is being the limitation of this component in term of selection features, flexibility 
and other additional computational advantages.) and MINET package (for co-
expression analysis).  
 
 
Figure 33 – Overall project future potential directions. 
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The overall idea of our perspectives is to have a full web-based integrated analysis 
solution, for users with limited or advanced microarray knowledge. With this solution 
users will not have to spend precious time looking for and downloading datasets to 
analyze, reading different analytical methods literature in order to be able to 
implement them, interpreting the analysis results (Figure 34). A summary sheet, with 
corresponding nodes (gene-products) outlined by comparing the inferred co-
expression networks and maps depicted from KEGG or DAVID on tested genesets 
(obtained via the use of various differential analysis methods implemented in FAERI 
or Pegase), will be generated.  
Before this project, we initially focused our work on providing appropriate microarray 
analysis tools with the aim of enhancing prediction of genes of interest. However, 
these tools do not perfectly outcome full group of genes underlying a full biological 
phenomenon. We, most of the time, need to complete prediction from these analysis 
tools by additional information to depict a whole functional and informative gene 
group. Apart conducting this task experimentally, we can further reduce this work by 
enhancing our gene group prediction. This can be achieved by availing tool capable of 
visualizing and manipulating gene networks. 
The outcome envisioned in this perspective is to generate potential gene networks to 
be compared as a validation mechanism. However, the challenges at this level no 
visualization tool offers mapping features (indicate potential pathways, gene and 
protein information, molecular function of nodes…).  
We proposed in the second part of this thesis a novel gene (-product) co-expression 
networks visualization tool, which, using PathEx database component touching 
annotation information such gene, protein and pathway information, allows users to 
generate, complete and validate gene (-product) co-expression networks of interest.   
 
 
Figure 34 - Overall envisioned analysis pipeline. 
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gViz: a novel co-expression networks visualization tool 
 
Introduction 
Gene expression data have been widely used to study different biological processes 
and mechanisms. Deriving gene (-product) co-expression networks are often used to 
extract information about groups of gene (-product)s that are 'functionally' related or 
co-regulated. However, it has been very difficult to study and fully compare these co-
expression networks obtained from gene expression data with known biological 
networks. 
These gene (-product) co-expression networks present however some caveats, which  
mainly originates from inappropriate technologies used to both visualize and identify 
the co-expression network components and their interactions involved in a given 
biological mechanism. Recently, construction of gene (-product) co-expression 
networks from expression data has recently become an alternative to the standard 
analytic approaches, such as the detection of differential expression using statistical 
methods. Therefore, there is a great need of another approach. By combining 
network theory, biological annotation data, microarray data analysis techniques and 
advanced graphical features, we developed an innovative, effective and simple to use 
gene (-product) co-expression networks visualization tool, which can be used to 
interpret and unravel new biological mechanisms in a simple manner. 
Gene (-product) co-expression networks have been used to demonstrate that 
functionally related gene products are frequently co-expressed across multiple 
datasets (Fang, et al., 2009). While constructing co-expression networks, it is 
important to choose the appropriate tool.  
In this part, we present a novel gene (-product) co-expression networks visualization 
tool combining network theory, biological annotation data, microarray data analysis 
techniques and advanced graphical features. 
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gViz methods and implementation 
 
Rationale 
Merging of network theories, public biological data knowledge and microarray data 
analysis techniques presents an unexploited opportunity to explore and understand 
the functionality of genes. It has been assumed that similar patterns in gene 
expression profiles suggest relationships between genes (Yu, et al., 2003) (Chiang, et 
al., 2001) and it is important to discover these relationships between co-expressed 
genes using co-expression matrices from microarray data. While co-expression 
networks construction may be straightforward, we do limit our work by presenting a 
visualization tool to investigate the existence of co-expression between genes leaving 
to other studies the important question of stating whether it is biologically 
meaningful to represent a gene by a network node and a functional relationship by 
an edge. 
Built around clustering coefficient-based algorithms, gViz relies on a novel approach 
to visualize and manipulate networks of co-expression interactions among a selection 
of probesets (each probeset representing a single gene or transcript), based on a set 
of gene co-expression data stored as an adjacency matrix. This adjacency matrix, 
representing numerically the relationships between probesets, can be inferred by 
using co-expression data computational tools such as MINET (Meyer, et al., 2008), an 
R package allowing computing co-expression relations between probesets and 
through several microarrays.  
The inference of an interaction network is a relatively new domain in bioinformatics. 
However, several algorithms are available, the following list not being exhaustive: 
Bayesian approach-based algorithms, such as the package GeneTS (Schafer and 
Strimmer, 2005), neuronal computation model algorithms, such as the “neuro-fuzzy” 
(Birney, et al., 2006) approach or mutual information computation based algorithms, 
such as MINET or qpGraph (Castelo and Roverato, 2009). We chose MINET for several 
reasons: at each step of the computation process, there is the possibility to choose 
between alternative methods and to set different parameters; the methods 
contained within the algorithm are at the edge of current knowledge in the domain; 
and finally we had the possibility to interact with the developers of the package to 
refine some steps of the computation to improve what represented a drawback for 
us to generate adjacent matrix. MINET accepts pretreated microarray data (we 
recommend to use the GCRMA (Wu, et al., 2004)  pretreatment method (for the 
reasons out of scope of this thesis but proved to be adequate) and provides a co-
expression matrix in the form of a GraphML file.   
Even if input co-expression matrices are based on probeset identifiers, gViz provides 
users with advanced features to visualize corresponding interaction networks using 
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other associated identifiers, such as gene identifiers (EntrezGene id’s, Ensembl id’s, 
UniGene (Huynh, et al., 2009) id’s  and gene symbols), protein identifiers (SwissProt 
accession numbers) and disease identifiers (OMIM (Rashbass, 1995) id’s). 
 
State of the art 
There are several programs designed to analyze biological networks, the most known 
being Cytoscape (Shannon, et al., 2003). Although it is a major first class visualization 
program, we included in gViz some unique and convenient functionality, first of 
which is the capacity to compute and display sub networks. We also noticed that gViz 
is much more user-friendly and easy to use than most of the alternative solutions. 
Although displaying a huge network containing tens of thousands of nodes and a 
hundred times more edges is technically possible, it would not humanly be efficient 
to identify specific parts of that network. It is in this context that gViz proposes 
different features that allow the user to display only parts of the network of interest. 
Then user can select one or more identifiers in a list deriving from a provided data set 
and display the sub-network containing only the relationships it wants to focus on. A 
slider feature "deepness" provided can be used to adjust gradually the neighborhood 
of the selected identifiers: if n identifiers are selected and a deepness of d is chosen, 
the sub-network displayed will include the n identifiers and all their neighbors at a 
distance of maximum d edges. For example, selecting a single node and a deepness of 
2 will display the selected node, its immediate neighbors and neighbors of the latter. 
It is also possible to set deepness to "maximum", hence displaying all neighbors 
reachable from the selected identifiers, regardless of their distance. gViz allows also 
to filter the displayed relationships (edges) by excluding those having a weight under 
a given threshold (determined during the computational part in MINET; the weight 
represents the certainty of the selected interaction; i.e., if we consider a pair of nodes 
i and j, the weight of the arc between them is the maximum of the MRMR (maximum 
relevance / minimum redundancy) score computed in both directions.).  The user can 
at any time reduce (or increase) the number of edges displayed by eliminating those 
which are most likely to be false positive. Apart from filtering by edge weight, one 
can filter the node list by degree (i.e. number of neighbors) and/or by clusters (i.e. 
sub-networks without connection between them). The clusters are recalculated 
whenever the user changes the threshold of the edge weights, because they do not 
take into account edges excluded by the filter. Another prominent feature allows the 
user to find identifiers by providing annotation criteria (such as a description of a 
gene or its involvement in a biological process), and generate a sub-network using all 
or part of the search result. 
It is worth mentioning that gViz is, to our knowledge one of the few softwares which 
can display and analyze GraphML-based networks at the genome scale. The yed 
graph editor is another solution providing GraphML display capabilities; however it is 
less powerful and proposes fewer features than gViz. The GraphML format has been 
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introduced around year 2000 as a common network information exchange format. 
GraphML format becoming much a major player in network theory, gViz is a serious 
candidate for widespread GraphML analysis.  
 
Coding 
gViz is written in Java and uses JUNG 2 (Java Universal Network / Graph Framework, 
http://jung.sourceforge.net/) (Fisher and O'Madadhain), a Java library that provides a 
common and extendible language for the modeling, analysis, and visualization of data 
that can be represented as a graph or network. Annotation information displayed on 
the graph originates from a third-party MySQL database component (this database 
component derive from PathEx, a web-based, human-oriented, expression array 
datasets builder for researchers who need to generate organized microarray datasets 
efficiently and according to their specific needs). 
 
Results 
 
 
Figure 35 - Example of a co-expression network displayed by gViz. 
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Networks displayed by gViz (Figure 35) are dynamic and can be manipulated (Figure 
36); each node or group of nodes can be moved using the mouse. Several layout 
algorithms for automatically positioning graph nodes are available and the user is 
hence provided with the possibility to organize nodes differently depending on the 
complexity of the actual network. Other ‘visual’ features include the possibility to 
change the size and transparency of nodes, to set edge thickness proportional to 
their weight, or to set node diameter proportional to their degree.  Specific nodes can 
be selected directly on the network graph using the mouse or from a list of displayed 
identifiers, and their neighbors are highlighted (the number of neighbors is set using 
a desired distance). User can also generate differently colored clusters by choosing 
the number of edges to remove to form highly connected sub-networks, where these 
edges are identified using the Girvan and Newman clustering algorithm (Girvan and 
Newman, 2002).  
 
 
 
 When one or more nodes of the network are selected gViz displays a range of 
annotation information from the displayed sub-network (Figure 35): the list of direct 
neighbors (displayed or not in the sub-networks, and the neighbors reached by an 
edge below the threshold set for the weight of edges), and from a biological 
database: the probeset identifier, information on associated genes, biological 
processes, cellular components and molecular functions involved (from Gene 
Ontology (Ashburner, et al., 2000)), proteins (sequences from SwissProt and domains 
from InterPro (Boeckmann, et al., 2003) (Hunter, et al., 2009)), references in the 
literature (from PubMed), diseases in which corresponding genes are involved (from 
Figure 36 - gViz avails several features to manipulate generated networkS. 
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OMIM), chemical reactions and pathways in which these genes are involved (from 
KEGG and GenMAPP 2 (Salomonis, et al., 2007)).  
gViz also has two features that display the shortest path between two nodes, and 
highlight the edges of the sub-network that can be identified in a pre-selected KEGG 
pathway.  
 
 
 
Various statistics on the sub-network can be obtained, including histogram (Figure 
38) plots providing the user with the degree of network nodes distribution, the 
diameter of the subnetwork, the weight distribution of the edges, the graph 
distribution coefficient of clustering (Watts and Strogatz, 1998) and/or cluster size 
distribution. Finally, the displayed (sub-) network and its statistics can be exported in 
different data file formats. 
Figure 37 - gViz displays a range of annotation information for generated networks. 
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gViz methods validation 
To validate the effectiveness of gViz tool, we used a dataset initially published in an 
article we published related to hypoxia and normoxia in cancer cells. 
Then the chosen dataset was analyzed and a co-expression matrix computed for 
visualization. 
The obtained matrix was load into gViz and corresponding network generated. 
By superimposing the network obtained by gViz in submitting hypoxia key term to the 
co-expression matrix generated network, we notice that gViz is able to predict a co-
expression network without going by co-expression matrices computation. 
 
Concluding remarks 
We present in this thesis part, gViz, a novel software for visualization, exploration and 
analysis of GraphML-based genetic co-expression networks. We described step by 
step the rationale and utility of such simple but effective tool in case of visualization 
and inference of gene (-product) networks. gViz provides with convenient built-in 
filtering and displaying features and connects to an external (PathEx) database 
component containing information on genes, pathway and other annotation 
information. Once co-expression matrices obtained, for example using the R package 
“MINET”, gViz may help to explore and/or to map (partially and/or fully) the co-
expression relations of gene products in different biological states.  
Figure 38 -Example of a kind of a co-expression network’ statistics generated by gViz. 
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Resulting paper 
While developing gViz tool, the aim was to provide with users a tool, which, by using 
co-expression matrices, predicts gene (-product) co-expression networks. 
These co-expression networks being backbones of most interactions underlying 
(un)known biological phenomena such specific metabolic pathways and/or biological 
reactions or processes. 
The manuscript describing gViz has been submitted in BMC Research Notes as a 
software issue for review and publication. 
We have just received comments from the two appointed reviewers and they sound 
promising. While the first reviewer needs minor changes on the manuscripts and 
clarifications before expressing his/her view on the manuscript, the second found the 
manuscript positive and acceptable for publication after typographic errors 
correction. 
After first revision, the first reviewer accepted gViz for publication and the second 
accepted it after rephrasing a sentence he found ambiguous. We rephrased the 
sentence and re-submitted the revised manuscript again for publication. 
We hope to have gViz published shortly. 
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Abstract  
 
Background 
The quantity of microarray data available on the Internet has grown dramatically over 
the past years and now represents millions of Euros worth of underused information. 
One way to use this data is through co-expression analysis. To avoid a certain amount 
of bias, such data must often be analyzed at the genome scale, for example by 
network representation. The identification of co-expression networks is an important 
means to unravel gene to gene interactions and the underlying functional 
relationship between them. However, it is very difficult to explore and analyze a 
network of such dimensions. Several programs (Cytoscape, yEd) have already been 
developed for network analysis; however, to our knowledge, there are no available 
GraphML compatible programs.  
Results 
We designed and developed gViz, a GraphML network visualization and exploration 
tool. gViz is built on clustering coefficient-based algorithms and is a novel tool to 
visualize and manipulate networks of co-expression interactions among a selection of 
probesets (each representing a single gene or transcript), based on a set of 
microarray co-expression data stored as an adjacency matrix.  
Conclusions 
We present here gViz, a software tool designed to visualize and explore large 
GraphML networks, combining network theory, biological annotation data, 
microarray data analysis and advanced graphical features.  
 
Background  
The merging of network theories, public biological data knowledge and microarray 
data analysis techniques presents an unexploited opportunity to explore and 
understand the functionality of genes. Similar patterns in gene expression profiles 
have been assumed to suggest relationships between genes (Yu, et al., 2003) and it is 
important to discover these relationships between co-expressed genes using co-
expression matrices from microarray data. While the construction of co-expression 
networks may be straightforward, we limit our work to the presentation of a 
visualization tool to search for co-expression between genes and leave to other 
studies the important question of determining whether it is biologically meaningful to 
represent a gene by a network node and a functional relationship by an edge. 
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Several network exploration softwares have been developed these past years; each 
of them with particular pros and cons. We direct readers to the following review for 
more details on those programs (Gehlenborg, et al.; Suderman and Hallett, 2007). 
After testing some of the programs discussed in those reviews, we estimated there 
was an advantage to build our own visualization program, with several new features 
included.  
Our motivations for developing our program were to allow use of the GraphML 
(Graph Markup Language) format into a network visualization software and providing 
a biologists-oriented network exploration solution, both user-friendly and light. To 
the best of our knowledge, gViz is the only software capable of rendering dynamically 
GraphML networks. We are aware of the Cytoscape plugin ‘Graphmlreader’, however 
it is still in development and seems to be non-functioning at the moment.   
The GraphML format is based on XML structure and is therefore ideally suited as a 
common denominator for all kinds of services generating, archiving, or processing 
graphs. It supports attributed for nodes and edges, hierarchical graphs and is very 
flexible [4]. GraphML was developed as modern graph exchange format, suitable in 
particular for exchange between graph drawing tool and other applications, during 
the 8th Symposium on graph drawing (GD 2000). It has been developed with the 
following pragmatic goals in mind: simplicity, generality, extensibility and robustness 
[5]. We also noticed that this format is very compact and therefore allows for faster 
transfer or loading into software. One given network uses less storage space when 
encoded in GraphML format then, for example, in DOT format.  
gViz is a novel tool built around clustering coefficient-based algorithms to visualize 
and manipulate networks of co-expression interactions among a selection of 
probesets (each probeset representing a single gene or transcript), based on a set of 
microarray co-expression data stored as an adjacency matrix. This adjacency matrix, 
representing numerically the relationships between probesets, can be inferred using 
co-expression data computational tools such as MINET [6], an R package that 
computes co-expression relations between probesets, and several microarrays.  
The inference of interaction networks is a relatively new area in the field of 
bioinformatics. However, several algorithms are available, including but not limited to 
the following: Bayesian approach-based algorithms, such as the GeneTS package [7], 
neuronal computation model algorithms, such as the “neuro-fuzzy” *8+ approach, or 
mutual information computation-based algorithms, such as MINET or qpGraph [9]. 
We chose MINET for several reasons: at each step of the computation process, it is 
possible to choose between several methods and to set different parameters; the 
methods contained in the algorithm are at the cutting edge of current knowledge in 
the field; and finally we were able to interact with the developers of the package to 
refine certain steps of the computation. MINET accepts preprocessed microarray data 
(we chose to use the GCRMA [10] preprocessing method) and provides a co-
expression matrix in the form of a GraphML file.   
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Even if input co-expression matrices are based on probeset identifiers, gViz provides 
users with advanced features to visualize the corresponding interaction networks 
using other associated identifiers, such as gene identifiers (Entrez Gene IDs [11], 
Ensembl IDs [12], UniGene IDs [13] and gene symbols), protein identifiers (SwissProt 
Accession Codes [14]) and disease identifiers (OMIM IDs [15]). 
 
Implementation 
 
gViz is written in Java and uses JUNG 2 (Java Universal Network / Graph Framework, 
http://jung.sourceforge.net/), a Java library that provides a common and extensible 
language for the modeling, analysis and visualization of data that can be represented 
as a graph or a network. Annotation information displayed on the graph originates 
from an external microarray database, PathEx [16], a manually-curated web-based 
expression array dataset builder of human microarray data, for researchers who need 
to generate organized microarray datasets efficiently and according to their specific 
needs. 
 
Results and discussion 
 
Comparison with existing software 
Several programs have been designed for the analysis of biological networks, the best 
known of which is Cytoscape [17]. Although it is a major first class visualization 
program, we chose to develop gViz and to add some unique and convenient 
functionalities, the first of which is the capacity to compute and display sub-networks 
using several different built-in filters. This functionality, although potentially 
biologically important, does not have its counterpart in Cytoscape (see Figure 3). We 
also noted that gViz is much more user-friendly and easier to use than most of the 
alternative software packages. Although it is technically possible to display a huge 
network containing tens of thousands of nodes and a hundred times more edges, it 
would not be humanly efficient to identify specific parts of that network. In that 
context, gViz proposes various features that allow the user to display only parts of 
the network of interest. The user can then select one or more identifiers from a list 
deriving from a data set provided and display the sub-network containing only the 
relationships to be studied. A "deepness" slider feature provided can be used to 
gradually adjust the neighborhood of the selected identifiers: if n identifiers are 
selected and a deepness of d is chosen, the sub-network displayed will include the n 
identifiers and all their neighbors at a distance of a maximum of d edges.  
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For example, selecting a single node and a deepness of 2 will display the selected 
node, its immediate neighbors and neighbors of the immediate neighbors. It is also 
possible to set deepness to the "maximum", hence displaying all neighbors reachable 
from the selected identifiers, regardless of their distance.  
gViz can also filter the displayed relationships (edges) by excluding those with a 
weight under a given threshold (determined during the computational part in MINET; 
the weight represents the certainty of the selected interaction; i.e., if we consider a 
pair of nodes i and j, the weight of the arc between them is the maximum of the 
MRMR (maximum relevance / minimum redundancy) score computed in both 
directions.). The user can at any time reduce (or increase) the number of edges 
displayed by eliminating those which are most likely to be false positives.  
Apart from filtering by edge weight, one can filter the node list by degree (i.e. 
number of neighbors) and/or by clusters (i.e. sub-networks without a connection 
between them). The clusters are recalculated whenever the user changes the 
threshold of the edge weights, because they do not take into account edges excluded 
by the filter. Another prominent feature allows the user to find identifiers by 
providing annotation criteria (such as a description of a gene or its involvement in a 
biological process), and generate a sub-network using all or part of the search results. 
It is worth mentioning that, to our knowledge, gViz is one of the few software 
packages capable of displaying and analyzing GraphML-based networks at the 
genome scale. The yEd graph editor [18] is another piece of software able to display 
GraphML; however, it is less powerful and proposes fewer features than gViz. The 
GraphML format was introduced around the year 2000 as a common network 
information exchange format. As such, gViz is a serious candidate for widespread 
GraphML analysis. 
 
gViz functionalities 
Networks displayed by gViz are dynamic and can be manipulated; each node or group 
of nodes can be moved using the mouse. Several layout algorithms are available to 
automatically position graph nodes and the user can hence organize nodes differently 
depending on the complexity of the actual network. Other ‘visual’ features include 
the possibility to change the size and transparency of nodes, to set edge thickness as 
a function of their weight, or to set node diameter as a function of their degree. 
Specific nodes can be selected directly on the network graph using the mouse or from 
a list of displayed identifiers, and their neighbors are highlighted (the number of 
neighbors is set using a desired distance). Users can also generate colored clusters 
differently by choosing the number of edges to remove to form highly connected sub-
networks, where these edges are identified using the Girvan and Newman clustering 
algorithm [19].  
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When one or more nodes of the network are selected, gViz displays a range of 
annotation information from the displayed sub-network, such as the list of direct 
neighbors (displayed or not in the sub-networks) and the neighbors reached by an 
edge below the threshold set for the edge weight, and from a biological database, 
such as the probeset identifier, information on associated genes, biological processes, 
cellular components and molecular functions involved (from Gene Ontology [20]), 
proteins (sequences from SwissProt and domains from InterPro [21]), references in 
the literature (from PubMed [22]), diseases in which corresponding genes are 
involved (from OMIM), chemical reactions and pathways in which these genes are 
involved (from KEGG [23] and GenMAPP [24]). gViz also has two features that display 
the shortest path between two nodes and highlight the edges of the sub-network 
that can be identified in a pre-selected KEGG pathway. Various statistics on the sub-
network can be obtained, including histogram plots providing the user with the 
degree of network node distribution, the diameter of the sub-network, the weight 
distribution of the edges, the graph distribution coefficient of clustering [25] and/or 
the cluster size distribution. Finally, the displayed (sub-)network and its statistics can 
be exported into different image and data file formats. 
 
Case study 
In this section, we will give an example of how to collect data, generate a GraphML 
using Minet and R and explore the resulting graph in gViz.  
Data collection  
There are several web repositories for microarray data (GEO [26], Array Express [27]). 
We recommend the use of our database PathEx, for easier and faster data collection.  
Network Computation  
We use the following packages to compute our networks: GCRMA, Minet and 
Infotheo (all of which freely available for download in Bioconductor).  
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Here follows the R code to compute the network from microarray .cel files (for R>= 
R2.10)  
library(gcrma) 
library(minet) 
cel<-list.celfiles() 
a<-ReadAffy(filenames=cel) 
b<-gcrma(a) 
c<-exprs(b) 
d<-t(c) 
disc<-discretize(d, disc= "equalfreq ", nbins=sqrt(nrow(d))) 
mim<-mutinformation(disc) 
net<-mrnet(mim) 
write.table(net, file= "net.txt ", sep= " \t") 
 
Once these steps are done (which can be long, depending on the computer’s speed 
and dataset size), one can import the network computed into gViz.  
gViz exploration  
Once the network is loaded in gViz (using the ‘open’ button ,1-, see figure 4 and the 
gViz manual), the list of the available nodes (genes) is shown in the lower left panel 
{2}. To display the entire graph, first select the ‘circle’ layout ,3- then click on ‘display 
full graph’,4-. The circle layout is recommended for its low computational needs; 
rendering a very large network can be extremely resource consuming. However, this 
step allows for a first overview of the network. At this step, one might want to filter 
his graph, using the filter on the Minet score {5}, or the filter on the number of 
neighbors {6}. One can also use the clustering option {7} to group similar nodes, by 
removing progressively the weakest edges in the graph (controlled by the ‘edge 
removed for clustering’ slider ,8-). Then, using the selection tool ,9-, one highlights 
the nodes of interest, then hits the ‘remove non-selected nodes’ button ,10-. The 
resulting sub-graph can then be shown using another, more explicit, layout (for 
example, ‘force-directed’).  
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The different layouts available in gViz have different uses: the ‘circle’ layout suits best 
the very big graphs, as it requires less computational power to be displayed. When 
working on a mid-sized sub-graph (less than 1,000 nodes), the ‘Kamada-Kawai’ or 
‘Fruchterman Reingold‘ layouts are suggested. ‘Force directed’ or ‘Meyer’s self 
organizing’ layouts are suited best for small (less than 100 nodes) networks, as they 
need more computational power to work but better discriminate the edges.  
To compute the shortest path between two nodes, first select the ‘shortest path’ tool 
{11}, click on the first node of interest then maintain the SHIFT key and click on the 
second node. gViz automatically computes the shortest path between those two 
nodes, with respect to the filters possibly applied. This feature can also be controlled 
via the left panel ,11’-. The shortest path can be exported using the ‘Export shortest 
path’ button ,12-. 
It is possible to export the current graph in image (click on ‘export network (png)’ 
button ,12-) or in various text formats (using the ‘export network (text)’ button ,13-).  
To obtain information on a certain node, one simply clicks on its name in the lower 
right panel {14}, displaying all the information contained in the PathEx database for 
this particular gene (for more information about PathEx, see [16]). 
 
Conclusions  
This manuscript presents gViz, a new software package for the visualization, 
exploration and analysis of GraphML-based genetic co-expression networks. It has 
many convenient built-in filtering and displaying features and is connected to an 
external database containing gene and annotation information. In conjunction with 
the MINET R package, we use gViz to explore the co-expression relationships of genes 
in different cellular states. 
 
Availability and requirements 
gViz is available at http://urbm-cluster.urbm.fundp.ac.be/webapps/gviz for 32 and 64 
bit Windows, MacOS X and Linux/Unix. It requires Java engine 1.6 or higher to run 
(http://java.com). To connect with the external database PathEx, the port 3306 of the 
user’s computer must be opened. This port may be blocked by a firewall and thus 
users must ask their network administrator to unblock it for their machine, if 
necessary. gViz is available under the Open GPL license.  
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Figures 
 
Figure 1  - Screenshot of the general interface of gViz 
 
 
 
This is the interface of a typical analysis in gViz. The center panel displays the current 
network. The top panel contains the visual functionalities. The left panel contains the 
different sliders as well as the clustering and comparison tools. Finally, the right panel 
shows the information contained in PathEx on the nodes selected in the current 
network.  
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Figure 2  - Zoom of the top, left and right panels 
 
 
 
Detailed view of the top panel where are grouped the visual tools of gViz, left panel 
containing the sliders along with the clustering and comparison tools and right panel 
presenting the information from PathEx on the selected genes, as well as slider to 
adjust the selection deepness.  
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Figure 3 – Case Study of gViz 
 
 
 
This figure displays a network filtered by the number of neighbors (> 2) and the Minet 
score (score > 0.5). The filters are triggered by the buttons in {1} and {2}, and controls 
for the filters are accessed in the left lower panel {3}.  
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Figure 4 – Filters in gViz 
 
 
 
Detailed view of the gViz interface and locations of the tools mentioned in the ‘case 
study’ section. Legend: 1 – Open button; 2- Lower left panel, list of nodes available; 3- 
Layout control button; 4- Display full graph button; 5- Filter on edges scores; 6- Filter 
on number of neighbors; 7- Clustering button; 8- Edges removed for clustering 
control slider; 9- Selection tool; 10- Remove non-selected nodes buttons; 11- Shortest 
path tool; 12- Export shortest path button; 13- Export network (png); 14- Export 
network (text); 15- Lower right panel, information on selected nodes. 
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Summary & Conclusions 
DNA microarray technology is a powerful research tool that enables the global 
measurement of changes between paired RNA samples. While strong biological 
inferences can be made from microarray data, they must be made within the proper 
biological and experimental context. This is because DNA microarrays capture a static 
view of a dynamic molecular event. This static view challenges researchers to unravel 
meaningful biological changes from the associated noise (due to sample acquisition, 
target labeling, microarray processing, etc.) 
DNA microarrays are notorious for generating noisy data. A common strategy for 
reducing or eliminating the effects of noise is to perform many experimental 
replicates.  
This approach is often costly and sometimes impossible given limited resources; thus, 
other approaches are needed which increase accuracy at no additional cost. One 
inexpensive source of microarray replicates comes from prior work: to date, data 
from hundreds of thousands of microarray experiments and biological information 
are in the public domain.  
Although these data assay a wide range of conditions, they cannot be used directly to 
inform any particular experiment and are thus ignored by most analysis methods. 
We envision PathEx as a means to maximize the potential for biological discovery 
from biological and microarray pre-knowledge, and we provide it as a freely available 
software package that is immediately applicable to any human microarray study.  
Several analytical methods have been proposed to resolve this noise issues. They 
mainly focus on estimating noise assuming that the level of the latter is signal 
intensity dependent. To achieve this estimation they propose to use a set of replicate 
arrays with varying degrees of experimental differences. However, a plethora of 
different analytical methods (with different outcomes) has led to the question of 
reproducibility of gene expression data, hampering hopes researchers have had with 
the advent of microarray technology. 
As the main goal of any biological experiment is to understand a specific mechanism, 
we proposed in this thesis another approach, which coupled with existing microarray 
analytical methods, may implicitly and substantially filter technical noise (biological 
noise being unavoidable and even informative).  
The advantage of one of the presented approach (PathEx) is that it resolves at the 
same time the issue of lack of replicates in addition to the provision of possibility to 
design and generate automatically user and focus driven datasets. 
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PathEx exploits thousands of public availed gene expression data from major public 
repositories, re-annotate them using an expert system combining various biological 
information sources (gene, protein, pathway, disease, ontology, interaction…), 
structure and organize them into a web based relational database.  
By proceeding this way, we created a new microarray knowledge base, which can be 
used by researchers with limited financial means (considering the cost of microarray 
technology) and with limited knowledge of microarrays (users do not need to know 
the type and structure of various sources integrated into the outcome solution of this 
approach). 
We presented PathEx, a database-principled, biological data-driven approach, to 
increase the power of microarray experiments in interpreting (predicting and 
validating) differentially expressed genes and biological phenomena related gene 
groups.  
We achieved this by designing and implementing a novel web-based microarray 
database tool combining together microarray datasets form GEO and ArrayExpress 
and a series of biological annotation information to further characterize those 
datasets. 
We demonstrated all along this thesis the power of this tool and we believe that use 
of the presented tool will help to interpret, validate and further develop biological 
new hypotheses without the need to conduct new experiments. 
On the other side, we detailed how by using a newly developed, effective network 
visualization tool such as gViz (with its advanced mapping capabilities), we can easily 
interpret biological phenomenon candidates with the support of knowledge 
contained in various biological sources integrated into PathEx database backend 
components. 
We showed that there are still ways to improve predictive and validation power of 
existing analysis methods by considering new approaches that have never been 
envisioned up to now. We believe the tools developed (and provided), without being 
ultimate solutions, contribute to better advancement of biomedical research. 
There are, however, common drawbacks that researchers face when interpreting 
DNA microarray results. The recognition of these drawbacks will help minimize false 
leads and maximize the biological meaning of the resulting microarray analysis. 
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Among these drawbacks we may mention, without being exhaustive, that: 
 Although replicate experiments offer statistical benefits, researchers should be 
aware that different levels of replication provide different answers. 
 DNA microarray results generally include genes that are considered 
“differentially expressed” between RNA samples and genes that are 
considered unchanged between samples. This distinction is determined by 
statistical tests using the spot intensity value for each gene. Although the use 
of statistics is recommended for defining differential expression, the statistical 
confidence of differential expression calls may not always reflect the biological 
relevance.  
 While many researchers focus on the handling of DNA microarrays, they 
should also recognize that the design of an experiment is as important as the 
implementation of the experiment. 
 The goal of any measurement tool is to provide an estimate of quantitative 
truth. In case of microarrays, this truth is of differential gene expression. And, 
like other quantitative tools, DNA microarray measurements are typically 
associated with an estimate of measurement error. 
 The proper interpretation of DNA microarray results should always be done 
within the context of biological information, experimental design, and 
statistical output. If pursued independently, each individual path could result 
in misleading biological interpretation.  
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Appendices 
List of acronyms 
ADF Array Design Format
AE Array Express
AJAX Asynchronous JavaScript and XML
ANOVA ANalysis Of VAriance
API Application Programing Interface 
BMC Biomedical Center
CDM Conceptual Diagram Model
cDNA complementary Desoxyribonucleic Acid
CGI Common Gateway interface
CL Cyclic Loess
cRNA complementary Ribonucleic Acid
CSS Cascading Style Sheet
DAVID Database for Annotation, Visualization and Integrated Discovery
DBMS Database Management Systems
DNA Desoxyribonucleic Acid
EBI European Bioinformatics Institute
EER Enhaced Entity Relation
ER Entity Relation 
FDR False Discovery Rate
FPR False Positive Rate
FWER Family-Wise Error Rate
GCRMA GC Robust Multi-array Average
GEO Gene Expression Omnibus
GO Gene Ontology
HTTP Hypertext Transfer Protocol
IM Ideal Mismatch
JUNG Java Universal Network Graph
KEGG Kyoto Encyclopedia of Genes and Genoms
LAMP Linux Apache MySQL PHP/Pythom/Perl
LDC Logical Diagram Model
LPE Local Pooled Error
MAGE Microarray Gene Expression
MaRe Microarrary Retriever
MAS Microarray Affymetrix Suite
MM Mismatch
mRNA messenger Ribonucleic Acid
MVC Model-View-Controller
NCBI National Center of Biotechnology
OMIM Online Mendelian Inheritance in Man
OOP Object Oriented Programming 
OS Operating System
PDM Physical Diagram Model
PM Perfect Match
RMA Robust Multichip Areraging 
RHEL Red Hat Enterprise Linux
RNA Ribonucleic Acid
rRNA ribosomal Ribonucleic Acid
SB Specific Background
SD Standard Deviation 
SDRF Sample and Data Relationship Format
SOFT Simple Ombibus Format on Text
tRNA transfer Ribonucleic Acid
VEGA Vebrate Genome Annotation
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Supplementary tables 
 
Table 6 - PathEx JavaScript methods 
Pathex JavaScript Methods 
Methods  Description 
get_grid() Return the object of the grid that contains the element. 
get_row() Return the object of the row that contains the element. 
get_tableview() Return the object of the tableview that contain the element. 
grid_cancel_edit() Cancel editing for the row that contains the element. 
grid_cancel_insert() Cancel inserting new row for the tableview that contains the element. 
grid_collapse() Make the row that contains the element collapse its table details. 
grid_confirm_edit() Confirm editing for the row that contains the element. 
grid_confirm_insert() Confirm inserting new row for the tableview that contains the element. 
grid_delete() Delete the row that contains the element. 
grid_edit() Start editing the row which contains the element. 
grid_expand() Make the row that contains the element expand its table details. 
viii 
 
grid_gopage() Make tableview that contain the element navigate to certain page. 
grid_insert() Start inserting new row for the tableview that contains the element. 
grid_refresh() Make the grid that contains the element refresh. 
grid_sort() Sort the column with specified id. 
grid_toggle_select() Toggle selection for the row that contains the element.  
ix 
 
 
Table 7 - PathEx data dictionary 
Name Description Code Data Type Length 
chromosome Unique chromosome accession ID chromosome 
Variable 
characters 
(5) 
5 
g2p_id Unique gene accession ID associated with a Platform g2p_id Integer  
gene_name Unique name describing a Gene gene_name 
Variable 
characters 
(200) 
200 
gene_symbol NCBI EntrezGene assigned Gene Symbol gene_symbol 
Variable 
characters 
(15) 
15 
omim_number NCBI OMIM assigned number omim_number 
Variable 
characters 
(20) 
20 
organism_id Unique organism accession ID organism_id Integer  
x 
 
organism_name Scientific name associated to an organism organism_name 
Variable 
characters 
(200) 
200 
p2s_id Unique Platform accession number associated with a Sample p2s_id Integer  
path_id Pathway database automatically assigned internal ID path_id 
Variable 
characters 
(20) 
20 
path_name Unique name describing Pathway path_name 
Variable 
characters 
(200) 
200 
pid Platform database automatically assigned internal ID pid 
Variable 
characters 
(20) 
20 
pl 
Unique Platform accession number approved and issued by 
GEO, AE 
pl 
Variable 
characters 
(10) 
10 
pl_distribution Microarrays are 'commercial', 'non-commercial', or 'custom-
commercial' in accordance with how the array was 
pl_distribution Text  
xi 
 
manufactured. 
pl_manufacturer 
Name of the company, facility or laboratory where the array was 
manufactured or produced 
pl_manufacturer Text  
pl_sub_date Platform date submitted pl_sub_date Date  
pl_technology 
the category describing the Platform technology: spotted 
DNA/cDNA, spotted oligonucleotide, in situ oligonucleotide, 
antibody, tissue, SARST, RT-PCR, MS, or MPSS 
pl_technology Text  
pl_title Platform unique name describing the Platform  pl_title Text  
pl_upd_date Platform date last updated pl_upd_date Date  
pubmed_id NCBI PubMed identifier (PMID) pubmed_id 
Variable 
characters 
(20) 
20 
px_id Series database automatically assigned internal ID px_id Integer  
s2s_id unique Series accession number associated with a Sample s2s_id Integer  
se Series unique accession number approved and issued by GEO, se Variable 10 
xii 
 
AE characters 
(10) 
se_status Series date released to public se_status Text  
se_sub_date Series date submitted se_sub_date Date  
se_summary A description of the goals and objectives of a study  se_summary Text  
se_title Unique name describing the overall study se_title Text  
se_type 
Keyword(s)generally describing the type of study, e.g., time 
course, dose response, comparative genomic hybridization, 
ChIP-chip, cell type comparison, disease state analysis, stress 
response, genetic modification, etc. 
se_type 
Variable 
characters 
(45) 
45 
se_upd_date Series date last updated se_upd_date Date  
sec_id Sample database automatically assigned internal ID sec_id 
Variable 
characters 
(32) 
32 
sm 
unique Sample accession number approved and issued by GEO, 
AE 
sm Variable 
characters 
10 
xiii 
 
(10) 
sm_count_channel number of labeling channels, could be 1 or 2 sm_count_channel Integer  
sm_description 
List of characteristics of the biological source, including factors 
not necessarily under investigation, e.g., Strain: C57BL/6, 
Gender: female, Age: 45 days, Tissue: bladder tumor, Tumor 
stage: Ta. Multiple characteristics columns can be included 
sm_description Text  
sm_row_count Number of data rows sm_row_count Integer  
sm_source1 
Name to identify the biological material and the experimental 
variable(s), e.g., vastus lateralis muscle, exercised, 60 min 
sm_source1 Text  
sm_source2 
Name to identify the biological material and the experimental 
variable(s), e.g., vastus lateralis muscle, exercised, 60 min 
sm_source2 Text  
sm_status Sample date released to public sm_status Text  
sm_sub_date Sample date submitted sm_sub_date Date  
sm_title Unique name describing a Sample sm_title Text  
sm_type Type of samples, values in current database are genomic, mixed, sm_type Text  
xiv 
 
MPSS, protein, RNA, SAGE, SARST, other 
sm_upd_date Sample date last updated sm_upd_date Date  
source_code Data source automatically assigned internal ID source_code 
Variable 
characters 
(45) 
45 
source_data_type Type of data source: gene, pathway,… source_data_type 
Variable 
characters 
(45) 
45 
source_name Data source name source_name 
Variable 
characters 
(100) 
100 
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Table 8 -List of datasets drawn by PathEx in the course of case study validation (Meta-analysis) 
Experiment/Study Accession 
numbers (keywords used) 
Platform Source Availability Experimental conditions 
E-GEOD-1323 (metastasis) HG-U133A AE Available 3 human colorectal cancer derived from a primary tumor 
VS. 3 corresponding lymph node metastases 
E-GEOD-2280 (metastasis) HG-U133A AE Available 8 squamous cell carcinoma of the oral cavity VS. 19 
corresponding lymph node metastases 
E-MEXP-44 HG-U95Av2 AE Available 15 head and neck squamous cell carcinoma VS. 3 
corresponding lymph node metastases 
HG-UgeneFL 12 head and neck squamous cell carcinoma VS. 11 
corresponding lymph node metastases 
GSE1056 HG-U95Av2 GEO Not available for 
public use 
2 human hepatocellular carcinoma under hypoxia for 2 
hours VS. 2 control human hepatocellular carcinoma 
2 human hepatocellular carcinoma under hypoxia for 24 
hours VS. 2 control human hepatocellular carcinoma 
GSE2280 (metastasis) HG-U133A GEO Available 22 squamous cell carcinoma of the oral cavity VS. 5 
corresponding lymph node metastases 
xvi 
 
GSE2603 (Not maching provided 
keywords!!!) 
HG-U133A GEO Available 100 primary breast cancer VS. 21 lung metastases 
GSE3325 (metastasis) HG-
U133Plus2.0 
GEO Available 7 primary prostate cancer VS. 6 metastases 
GSE4086 (hypoxia) HG-
U133Plus2.0 
GEO Available 2 human Burkitt’s lymphoma under hypoxia VS. 2 control 
human Burkitt’s lymphoma 
GSE468 HC-G110 GEO Available 13 primary medulloblastomas VS. 10 metastatic 
medulloblastomas 
GSE4840 HG-U133A GEO Not available for 
public use 
3 samples from normal melanocyte culture VS. 12 samples 
from culture of cutaneous metastasis of melanoma 
HG-U133B 3 samples from normal melanocyte culture VS. 12 samples 
from culture of cutaneous metastasis of melanoma 
GSE4843 HG-
U133Plus2.0 
GEO Not available for 
public use 
45 samples from culture of cutaneous melanoma metastasis 
GSE6369 (prostate) HG-
U133Plus2.0 
GEO Available 1 primary prostate carcinoma VS. 1 metastatic prostate 
carcinoma 
GSE6919 (prostate) HG-U95Av2 GEO Available 65 primary prostate tumors VS. 25 metastatic prostate 
xvii 
 
tumors 
HG-U95B 66 primary prostate tumors VS. 25 metastatic prostate 
tumors 
HG-U95C 65 primary prostate tumors VS. 25 metastatic prostate 
tumors 
GSE7929 (metastasis) HG-U133A GEO Available 11 poorly metastatic melanoma VS. 21 highly metastatic 
melanoma 
GSE7930 (metastasis) HG-U133A GEO Available 3 poorly metastatic prostate tumors VS. 3 highly metastatic 
prostate tumors 
GSE7956 (metastasis) HG-U133A GEO Available 10 poorly metastatic melanoma VS. 29 highly metastatic 
melanoma 
GSE8401 (metastasis) HG-U133A GEO Available 31 primary melanoma VS. 52 melanoma metastasis 
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Table 9 - List of metadata sets drawn by PathEx in the course of proofing stage validation (Enhanced meta-analysis study) 
Meta-
dataset 
Name 
Experimental conditions GeneChip 
models 
Datasets 
Meta-
dataset 1 
Primary tumor, normal tissue, poorly metastatic tissue VS. 
metastasis, highly metastatic tissue 
HG-U133A E-GEOD-1323, E-GEOD-2280, 
GSE2280, GSE2603, GSE4840 (HG-
U133A), GSE7929, GSE7930, GSE7956, 
GSE8401 
Meta-
dataset 2 
Primary tumor, poorly metastatic tissue VS. metastasis, highly 
metastatic tissue 
HG-U133A E-GEOD-1323, E-GEOD-2280, 
GSE2280, GSE2603, GSE7929, 
GSE7930, GSE7956, GSE8401 
Meta-
dataset 3 
Primary tumor, normal tissue VS. metastasis HG-U133A E-GEOD-1323, E-GEOD-2280, 
GSE2280, GSE2603, GSE4840 (HG-
U133A), GSE7929, GSE7956, GSE8401 
Meta-
dataset 4 
Primary tumor VS. metastasis HG-U133A E-GEOD-1323, E-GEOD-2280, 
GSE2280, GSE2603, GSE4840 (HG-
U133A), GSE7929, GSE7956, GSE8401 
xix 
 
Meta-
dataset 5 
Primary tumor VS. metastasis HG-U133A E-GEOD-1323, E-GEOD-2280, 
GSE2280, GSE2603, GSE7929, 
GSE7956, GSE8401 
Meta-
dataset 6 
Squamous cell carcinoma of the oral cavity VS. corresponding 
lymph node metastases 
HG-U133A E-GEOD-2280, GSE2280 
Meta-
dataset 7 
Normal melanocyte culture, poorly metastatic melanoma, 
primary melanoma VS. culture of cutaneous metastasis of 
melanoma, highly metastatic melanoma, melanoma 
metastasis 
HG-U133A GSE4840 (HG-U133A), GSE7929, 
GSE7956, GSE8401 
Meta-
dataset 8 
Poorly metastatic melanoma, primary melanoma VS. culture 
of cutaneous metastasis of melanoma, highly metastatic 
melanoma, melanoma metastasis 
HG-U133A GSE4840 (HG-U133A), GSE7929, 
GSE7956, GSE8401 
Meta-
dataset 9 
Poorly metastatic melanoma, primary melanoma VS. highly 
metastatic melanoma, melanoma metastasis 
HG-U133A GSE7929, GSE7956, GSE8401 
Meta-
dataset 10 
Primary tumor VS. metastasis HG-U95Av2 E-MEXP-44 (HG-U95Av2), GSE6919 
(HG-U95Av2) 
Meta-
dataset 11 
Hypoxia VS. normoxia HG-U95Av2 GSE1056 
xx 
 
Meta-
dataset 12 
Primary tumor, normoxia VS. metastasis, hypoxia HG-
U133Plus2.0 
GSE3325, GSE4086, GSE4843, 
GSE6369 
Meta-
dataset 13 
Primary tumor VS. metastasis HG-
U133Plus2.0 
GSE3325, GSE4843, GSE6369 
Meta-
dataset 14 
Primary prostate cancer VS. metastases HG-
U133Plus2.0 
GSE3325, GSE6369 
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PathEx data sources 
Table 10 - Sources and status of information integrated into PathEx 
No. Source Name Data Type PathEx Last Update Integrated
1 Entrez Gene gene December 14, 2010 Yes
2 ENSEMBL gene December 14, 2010 Yes
3 EMBL protein_xref December 14, 2010 Yes
4 KEGG Gene gene December 14, 2010 Yes
5 UniGene gene_xref December 14, 2010 Yes
6 UniProtKB/Swiss-Prot protein December 14, 2010 Yes
7 UniProtKB/TrEMBL protein December 14, 2010 Yes
8 ENSEMBL protein December 14, 2010 Yes
9 Entrez Gene interaction December 14, 2010 Yes
10 OMIM interaction December 14, 2010 Yes
11 Genome Expression Omnibus array expression December 14, 2010 Yes
12 Array Express array expression December 14, 2010 Yes
13 PubMed citations December 14, 2010 Yes
14 Gene Ontology ontology December 14, 2010 Yes
15 GenMAPP pathways December 14, 2010 Perspective
16 BioCarta pathways December 14, 2010 In process
17 WikiPathways pathways December 14, 2010 In process
18 KEGG Pathway pathway December 14, 2010 Yes  
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Additional illustrations 
 
PathEx data integration approach rationale 
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PathEx future dataset processing approach 
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PathEx future direction expected outcome maps example 
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PathEx web tool availability & deployment procedures 
 
PathEx core class deployment 
1. Unzip PathExCoreSuite.zip file from the CD. 
2. Copy PathExCoreSuite folder inside unzipped directory to your web server 
folder. 
3. Make sure that you have installed MySQL and PHP5. 
4. Start browsing the suite in web browser with url "http://your-web-server-
folder/ PathExCoreSuite /index.php". 
 
PathEx database component deployment 
1. Unzip PathExDB.zip file from the CD. 
2. Make sure that you have installed MySQL GUI Tools installed to your 
computer. 
3. Restore the unzipped file through MySQL GUI Administrator Tool 
 
PathEx interfaces deployment 
1. Unzip pathex.zip file from the CD. 
2. Move unzipped (pathex.zip) directory to your web server folder. 
3. Start browsing the suite in web browser with url "http://your-web-server-
folder/ pathex/index.php". 
 
Dataset builder deployment 
1. Unzip PathexBuilder.zip file from the CD. 
2. Move unzipped directory out of the web server folder. 
3. Edit the “config.tab” file appropriately 
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Note:  You will require contacting us to guide you how to import samples files 
used to build datasets. Make sure you have enough space on your server: 
“at least” 4TB disk space 
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gViz availability & deployment procedures 
 
Availability 
gViz is available at http://urbm-cluster.urbm.fundp.ac.be/webapps/gviz for 32 and 64 
bit Windows, MacOS X and Linux/Unix.  
 
Deployment procedures 
It requires Java engine 1.6 or higher to run (http://java.com).  
To connect with the external database PathEx, the port 3306 of the user’s computer 
must be opened. This port may be blocked by a firewall and thus users must ask their 
network administrator to unblock it for their machine, if necessary. gViz is available 
under the Open GPL license. Install instructions can be downloaded from either inside 
the application itself or from the web page of the application above mentioned. 
xxviii 
 
 
 
 
 
 
 
 
